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Abstract
The present study was conducted in order to develop rapid diagnostic assays on the
basis of conventional PCR which allow detection and discrimination of species,
subspecies and biovars of the potential bioterrorist agents Francisella, Brucella and
Yersinia not targeted by the currently established gel-based PCR assays. Reference
and field strains were analysed using RAPD and rep-PCR in order to find regions of
genetic heterogeneity in the genomes of the closely related species, subspecies and
biovars for each of the different genera. A number of promising differences could be
found in the resulting RAPD fingerprints. Distinctive bands were cloned in E. coli and
sequenced. Differences on the molecular level found through analysis of the obtained
sequence data as well as genome comparisons, together with expedient information
taken from previous external studies were used to develop specific and robust PCR
assays for typing and subtyping of the taxa Brucella and Francisella as well as an
assay that can identify atypical Yersinia pseudotuberculosis strains.
In addition to the commonly used PCR assays like the AMOS-PCR and some
variants thereof, the developed Brucella assay specifically identified Brucella
neotomae, Brucella pinnipedialis, Brucella ceti, and Brucella microti. Furthermore, it
differentiated Brucella abortus biovars 1, 2, 4 from biovars 3, 5, 6, 9, as well as
between Brucella suis biovar 1, biovars 3, 4, and biovars 2, 5. The Francisella
multiplex-PCR developed in the course of this study distinguished between the novel
Francisella species Francisella hispaniensis, representatives of all other Francisella
species and subspecies, clades A.I and A.II of Francisella tularensis subsp. tularensis
and Francisella tularensis subsp. holarctica biovar japonica. The novel Yersinia
triplex assay allowed for a clear distinction between Yersinia pestis and Yersinia
pestis-like Yersinia pseudotuberculosis strains and distinguished them from typical
strains of Y. pseudotuberculosis.
For a molecular comparison of strains and to assure the specificity of the
developed PCR assays, it was indispensible to determine unambiguously the
taxonomic status of field strains using the available methods. In collaboration with
colleagues from other institutes, a great number of field strains of Brucella and other
representatives of the family Brucellaceae, including Ochrobactrum,
Pseudochrobactrum and Paenochrobactrum, as well as strains of Francisella were
therefore classified applying classical microbiological and chemotaxonomical
methods, analyses of housekeeping genes (rrs, recA, gyrB, groEL), RAPD-PCR and
partly also DNA-DNA hybridization. Strains that could not be assigned to a
recognized species were proposed as novel species, leading to the description of two
Brucella species (B. microti, B. inopinata), five Ochrobactrum species (O.
pseudogrignonense, O. pituitosum, O. rhizosphaerae, O. haematophilum, O.
thiophenivorans), two Pseudochrobactrum species (Ps. kiredjianiae, Ps. lubricantis),
one Paenochrobactrum species (Paenochrobactrum gallinarii) and a novel
Francisella species (F. hispaniensis).
Zusammenfassung
Die vorliegende Studie wurde durchgeführt, um diagnostische Schnelltests auf der
Basis konventioneller PCR (Polymerase Kettenreaktion) zu entwickeln, die die
Detektion und Unterscheidung jener Arten, Unterarten und Biovare der potentiell
bioterroristisch nutzbaren Bakterien der Gattungen Francisella, Brucella und Yersinia
erlauben, die noch nicht durch gängige Gel-basierte PCR-Tests erkannt werden.
Referenzstämme und Feldisolate wurden mittels RAPD (randomly amplified
polymorphic DNA) und rep-PCR (gegen repetitive, nichtkodierende, intercistronische
Abschnitte gerichtet) analysiert, um Regionen genetischer Variabilität zwischen den
eng verwandten Arten, Unterarten und Biovaren der einzelnen Gattungen ausfindig
zu machen. Mittels dieses Ansatzes wurden in den resultierenden RAPD Mustern
spezifische PCR-Produkte gefunden. Diese Produkte wurden in E. coli kloniert und
dann sequenziert. Sequenzunterschiede, die im Vergleich zu in Datenbanken
hinterlegten Sequenzen identifiziert werden konnten, zusammen mit Informationen
aus diversen Veröffentlichungen, wurden verwendet, um spezifische und robuste
PCR Schnelltests zur Typisierung und Subtypisierung der Taxa Brucella und
Francisella zu entwickeln. Weiters wurde ein PCR-Test entwickelt, um Yersinia
pestis-ähnliche Yersinia pseudotuberculosis Stämme zu identifizieren.
Zusätzlich zu den allgemein gebräuchlichen PCR Tests wie der AMOS-PCR und
einigen ihrer Varianten kann der neu entwickelte Brucella Ansatz Brucella neotomae,
Brucella pinnipedialis, Brucella ceti und Brucella microti spezifisch detektieren.
Darüber hinaus konnte der Test die Brucella abortus Biovare 1,2,4 von den Biovaren
3,5,6 und 9, sowie auch Brucella suis Biovar 1 von den Biovaren 3,4 und 2,5
unterscheiden. Ein im Rahmen dieser Arbeit entwickelter Francisella Multiplex-
Ansatz differenzierte zwischen der neuen Art Francisella hispaniensis,
Repräsentanten aller anderer Francisella-Arten und Unterarten, F. tularensis subsp.
tularensis A.I und A.II Stämmen und Biovar japonica der Unterart F. tularensis subsp.
holarctica. Der neu entwickelte Yersinia Triplex-Ansatz ermöglichte eine spezifische
Unterscheidung von Y. pestis und atypischen Y. pestis-ähnlichen Y.
pseudotuberculosis Stämmen und unterschied sie auch gleichzeitig von anderen
Stämmen der Spezies Y. pseudotuberculosis.
Zur Evaluierung der entwickelten Tests war es unerlässlich, die taxonomische
Stellung einer Reihe von Feldisolaten zu bestimmen. Im Laufe dieser Studie wurden
deshalb zusammen mit Kollegen anderer Institute eine große Zahl an Feldisolaten
von Brucella und anderen Vertretern der Familie Brucellaceae (Ochrobactrum,
Pseudochrobactrum und Paenochrobactrum) wie auch von Francisella
charakterisiert, wobei klassische mikrobiologische und chemotaxonomische
Methoden sowie die Analyse konservierter Gene (rrs, recA, gyrB, groEL) und RAPD-
PCR Anwendung fanden. In einigen Fällen wurden auch DNA-DNA Hybridisierungen
durchgeführt, um den Speziesstatus von Stämmen eindeutig zu klären. Stämme, die
keiner etablierten Art zugeordnet werden konnten, wurden dann als neue Art
beschrieben; fünf Ochrobactrum Arten (O. haematophilum, O. rhizosphaerae, O.
pituitosum, O. pseudogrignonense, O. thiophenivorans), zwei Pseudochrobactrum
Arten (Ps. kiredjianiae, Ps. lubricantis), und eine Paenochrobactrum Art
(Paenochrobactrum gallinarii), zwei Brucella Arten (B. microti, B. inopinata) und eine
Francisella Art (F. hispaniensis).
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1. Introduction
1.1. Bioterrorism and biothreat agents
Bioterrorism has been a subject of increasing worldwide concern. In the last century,
especially between World War I and the early Cold War, there was active research
for biological weapons regardless of the prohibition of their use by the 1925 Geneva
Protocol. However, the anticipated growing danger for all parties led to an expanded
ban on the development, production, trading and use of microbial or other biological
and toxin weapons imposed by the 1972 Biological Weapons Convention (BWC)
which has hitherto been signed by more than 170 states. (Biological and Toxin
Weapons Convention website, http://www.opbw.org) However, policy makers are
currently seeking to strengthen the BWC because of the ongoing proliferation of
biological weapons and biotechnologies as well as the apprehended danger of
bioterrorist acts (Christopher et al., 1997; Eubanks et al., 2007). Additionally, there is
the fear that molecular biology and biotechnology could intentionally be used for the
manipulation of microbes to fit homicidal purposes which would add a new dimension
to warfare and terrorist threat in future (Cannons et al., 2006).
Among previous incidents of bioterrorist activities (Tucker, 1999), the most recent
anthrax attacks of 2001 in the U.S. directed political and scientific attention to the
problem of bioterrorism (Bossi et al., 2004a; Murphy, 2004; Schuler, 2004) and once
more emphasised the importance of epidemiological studies and of diagnostic tools
that can quickly and accurately identify infectious agents to facilitate a rapid response
in both, a bioterroristic event or naturally occurring outbreak. The diagnosis of the
classic bacterial agents of biological warfare (Bacillus anthracis, Yersinia pestis,
Francisella tularensis, Brucella spp., Burkholderia mallei, Burkholderia pseudomallei)
and other biothreat agents listed by the CDC and the U.S. Department of Health and
Human Services has thus become a very important subject of research over the last
decade. Various molecular diagnostic assays rapidly detecting and confirming
biothreat agents have already been developed (Oggioni et al., 2002; Ellerbrok et al.,
2002; Bell et al., 2002; Loïez et al., 2003; Lundquist et al., 2005; Wilson et al., 2005;
Ulrich et al., 2006; Larsson et al., 2007; Van Ert et al., 2007; Das et al., 2008; Yang
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Table 1. The clinical implications of Brucella spp., Yersinia pestis and Francisella
tularensis (adapted from Franz et al., 1997)
Agent
Infective
dose
(Aerosol)
Incubation
period
Diagnostic
samples
Clinical diagnostic
assay
Patient isolation
precautions
Brucella
spp. causing
brucellosis
10-100
organisms 5-60 days
blood, bone
marrow, serum
culture
serology: agglutination
standard precautions,
contact isolation if
draining lesions present
Yersinia
pestis
causing
plague
100-500
organisms 2-3 days
blood, sputum,
lymph node
aspirate
Gram or Wright-
Giemsa stain, antigen-
ELISA, culture,
serology: ELISA, IFA
pneumonic: droplet
precautions until patient
treated for 3 days
Francisella
tularensis
causing
tularemia
10-50
organisms 2-10 days
blood, sputum,
serum, EM of
tissue
culture,
serology: agglutination standard precautions
et al., 2008; Wang et al., 2009; Yang et al., 2009; Deshpande et al., 2010; Matero et
al., 2010).
1.2. Outline and methodology of the study
In the face of the recent terrorist attacks involving a biological threat agent, Bacillus
anthracis, research in the area of biodefense was also intensified in Europe. The
present study, supported by a Contract-Research Project of the German Ministry of
Defence (Grant No. M-SAB1-5-A005), was conducted in order to develop
differentiating PCR assays for rapid and accurate typing and subtyping of three highly
pathogenic proteobacterial taxa, namely Francisella, Brucella and Yersinia, causing
zoonotic diseases in humans and considered to have bioterroristic potential (for their
clinical implications see Table 1). Francisella tularensis and Yersinia pestis are
classified by the CDC as category (A) pathogens and Brucella spp. as category (B)
pathogens and thus are recognised as biological threat agents (Rotz et al., 2002).
None of these organisms are known to have been used in bioterrorist actions so far
but they have been thoroughly studied or applied as bioweapons and hence are
important subjects of research in the area of biodefense (Christopher et al., 1997).
So far, the major focus of diagnostic biodefense research has been on the
development and optimization of sensitive, specific and reproducible immunoassays,
real-time PCR assays, DNA microarrays and biochip arrays for immunological
detection, flow cytometry, and chemical and physical biosensors that can, often
Introduction
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simultaneously, detect a range of different biothreat agents at the species or genus
level (Lim et al., 2005). But, since especially taxa like Francisella tularensis with
several subspecies and biovars, the genetically and phenotypically highly similar
Brucella species with their biovars and other members of the family Brucellaceae and
Yersinia pestis with its biovars and being a clone of Y. pseudotuberculosis (Achtman
et al., 1999) can internally only be separated with difficulty and conventional typing
methods are risky for the lab personnel, the development of PCR-based assays that
primarily aim at subtyping those highly pathogenic taxa was a major reason for
carrying out this study.
The technology of choice for the diagnostic assays to be developed was
conventional gel-based PCR, on the one hand, because of the actual laboratory
equipment and expertise and, on the other hand, because it has become a worldwide
standard procedure and the assays are cost-effective and easy to reproduce without
any sophisticated know-how. The core strategy towards the development of the
assays for the studied taxa was to find genetically unique or highly variable regions in
the respective genomes via genomic fingerprinting (RAPD and rep-PCR).
Despite their high level of genomic similarity, there is a range of different methods
for the identification of group-specific variations in brucellae, F. tularensis and Y.
pestis/pseudotuberculosis that have shown the potential to identify useful biomarkers.
These include IS-anchored arbitrary PCR (Ouahrani-Bettache et al., 1996),
infrequent restriction site-PCR and restriction maps (Cloeckaert et al., 2003;
Michaux-Charachon et al., 1997), multilocus sequencing (Whatmore et al., 2007),
ribotyping (Verger et al., 2000), suppression subtractive hybridization (Radnedge et
al., 2001; Radnedge et al., 2002; Wang et al., 2006; Molins et al., 2008), comparative
whole-genome hybridization and DNA microarray analyses (Rajashekara et al., 2004;
Zhou et al., 2004b; Broekhuijsen et al., 2003; Zhou et al., 2004d) and whole-genome
sequence comparisons (Halling et al., 2005; Chain et al., 2005; Ratushna et al.,
2006; Chain et al., 2006). RAPD-profiles have been used to identify species-specific
DNA fragments in order to develop PCR assays for the identification of species within
bacterial taxa other than Brucella, Francisella and Yersinia (Manulis et al., 1994;
Guillot and Mouton, 1997; Teng et al., 2000; Brown et al., 2004). Since this method is
technically less demanding than others and has the potential to reveal not only
species-specific but also subgroup-specific differences within the conserved
genomes of the studied taxa (Fekete et al., 1992; Tcherneva et al., 1996; 2000;
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Mercier et al., 1996; Johansson et al., 2000; De La Puente-Redondo et al., 2000), the
approach of using RAPD and rep-PCR fingerprinting for the identification of
biomarkers seemed promising.
Successful detection of clearly differentiating bands was to be followed by excision
of the bands from the gel and cloning, sequencing and analysis of the DNA
fragments. The sequence information on differences within the conserved genomes
of Brucella species and biovars, Francisella tularensis subspecies and biovars and
strains of the Yersinia pestis/pseudotuberculosis group obtained through RAPD and
rep-PCR fingerprinting and subsequent analyses was to be used to design specifc
primers for the diagnostic assays which should then be able to differentiate highly
pathogenic members within Brucella, Francisella and Yersinia from less pathogenic
or non-pathogenic members and that do not only allow for a specific identification on
the species level, but also enable a differential detection of subspecies, biovars and
other subgroups, many of which had so far not been included in previously published
assays.
Also important was the often neglected exact determination of the taxonomic
status of the field strains to be used to determine the specificity of the novel assays.
Cultivation of Francisella, Brucella and Yersinia pestis strains and standard biotyping
of field strains was to be done in a biosafety level 3 laboratory (InstMikroBioBw
TE010) by our collaborators of the Bundeswehr Institute of Microbiology,
Neuherbergstraße 11, 80937 Munich. Other Yersinia strains and the Brucella-like
strains of the closely related genera Ochrobactrum and Pseudochrobactrum could be
cultivated without such special safety measures. In order to confirm the preliminary
affiliation of field strains determined in Munich, DNA-DNA hybridization, the gold
standard for species delineation, was to be carried out between the respective type
and field strains of the studied bacterial taxa. Whereas this method is not applicable
to Brucella species, which have to be discriminated via a set of conventional
diagnostic tests because of their high DNA homology (Verger et al., 1985; 2000), it is
very important in regard to Brucella-like strains which are – due to their close
relationship – sometimes misidentified as Brucella and vice versa (Scholz et al.,
2008a). Thus, the taxonomic status of a large number of Brucella-like strains was to
be determined by DNA reassociation experiments, classical microbiological and
chemotaxonomic methods, analyses of housekeeping genes and RAPD-PCR before
their use as negative controls in the Brucella-specific assay. Francisella test strains
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were also to be examined as to their taxonomic position before their use in
subsequent experiments. Strains identified as novel species were to be taxonomically
characterised and formally described.
1.3. Aims of the study
The main objectives of the present thesis are summarized as follows:
 identification of taxon or group specific genomic regions
 development of rapid, specific and sensitive taxon or group specific PCR assays for
typing and subtyping of the studied bacterial pathogens
 analysis of the taxonomic status of field isolates
 description of thereby detected novel species
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2. Genus Brucella
2.1. Introduction
2.1.1. Brucellosis
The different Brucella species are of medical importance because they can cause the
disease brucellosis in animals and humans. Brucella infection frequently leads to
abortion, lowered fertility and milk yield in productive livestock and is therefore
responsible for considerable economic losses (Collier et al., 1998; Wright, 1987). At
least the species B. abortus (host: cattle and bison), B. melitensis (host: goats and
cattle), B. suis (host: swine) and B. canis (host: dogs) are known as the causative
agents of human brucellosis (also named Mediterranean fever, Gibraltar fever, Malta
fever, Cyprus fever, undulant fever and typhomalarial fever; Young, 1995). B.
melitensis is the most pathogenic species for humans, followed by B. suis, B. abortus
and B. canis (Young, 1995). The disease can be acquired by inhalation of aerosols,
consumption of unsterilized dairy products or meat from infected animals or by
handling of infected animals but is rarely transmitted from human to human (Young,
1995). For marine brucellae, the disease neurobrucellosis in humans was described
(Brew et al., 1999; Sohn et al., 2003). Symptoms of brucellosis are rather unspecific,
including arthralgia, inconstant fevers, anaemia, weakness, headache, sweating,
depression and irritability (Young, 1995; Iserson, 2002). The disease often becomes
chronic and sometimes leads to death of mostly immunocompromised hosts, usually
because of B. melitensis endocarditis or meningitis (Bossi et al., 2004b).
Brucella species were of interest for bioweapon research because the agent can
be transmitted via the air and 10-100 organisms are enough to cause the disease in
humans (see Table 1). B. suis was the first bioweapon agent developed to be used in
bomblets by the USA (Endicott and Hagerman, 1998). Although Brucella species can
survive well in aerosols and resist desiccation, the weaponized agent proved to be
too ineffective (Bossi et al., 2004b). The incubation period can be long (see Table 1),
mortality is low and Brucella can be inactivated by exposure to heat and most
disinfectants (Bossi et al., 2004b). Nevertheless, the use as a bioterrorist agent
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cannot be ruled out since the effects of brucellosis, especially when inhaled, are quite
debilitating on a large scale.
2.1.2. Classification
Brucella strains have been isolated from a range of different terrestrial and marine
mammals (including humans) and recently also from a human breast implant wound
and a lung biopsy of a pneumonia patient (Scholz et al., 2010; Tiller et al., 2010). The
genus comprises now the six classical Brucella species Brucella melitensis (host:
goats), Brucella abortus (host: cattle), Brucella suis (host: mostly pigs and hares),
Brucella neotomae (host: desert wood rat), Brucella canis (host: dogs), Brucella ovis
(host: sheep), and the more recently described species Brucella ceti, Brucella
pinnipedialis (both from marine mammals), and two species described with
contributions from the present study, Brucella microti (host: common vole) and
Brucella inopinata (human). B. melitensis, B. abortus und B. suis are further divided
into biovars. Marine Brucella species have recently also been shown to contain
significant subtypes which might be assigned biovar status or even species status in
the future (Dawson et al., 2008; Maquart et al., 2009).
DNA-DNA hybridization studies showed that, according to the common taxonomic
rules (DNA homology >70%, Wayne et al., 1987) the classical species only represent
one species (Verger et al., 1985; 2000) and therefore should be combined into the
single genomospecies Brucella melitensis. Nevertheless, to avoid confusion, the
“Subcommittee on the taxonomy of Brucella” proposed to keep the nomen-species
(Osterman and Moriyon, 2006). Classification into the six classical species is mainly
based on the differences in phenotypic characteristics, pathogenicity and host
preference (Corbel and Brinley-Morgan, 1984). Also the novel marine species occur
in specific hosts. B. ceti is predominant in cetacean species like dolphins, minke
whales and porpoises and B. pinnipedialis is commonly isolated from pinnipeds like
hooded seals and other seal species. B. microti was originally isolated from common
voles but has recently been reported to infect red foxes as well (Scholz et al., 2009).
B. inopinata was currently only isolated from immunocompromised patients (Scholz
et al., 2010; Tiller et al., 2010).
Brucella and Brucella-like
8
Brucella is genetically closely related to the genus Ochrobactrum (Velasco et al.,
1998). The taxon Ochrobactrum currently contains fifteen species, O. anthropi
(Holmes et al., 1988), O. cytisi (Zurdo-Piñeiro et al., 2007), O. gallinifaecis (Kämpfer
et al., 2003), O. grignonense (Lebuhn et al., 2000), O. haematophilum (Kämpfer et
al., 2007b), O. intermedium (Velasco et al., 1998), O. lupini (Trujillo et al., 2005), O.
oryzae (Tripathi et al., 2006), O. pituitosum (Huber et al., 2010), O.
pseudintermedium (Teyssier et al., 2007), O. pseudogrignonense (Kämpfer et al.,
2007b), O. rhizosphaerae (Kämpfer et al., 2008a), O. thiophenivorans (Kämpfer et
al., 2008a), O. tritici (Lebuhn et al., 2000) and O. ciceri (Imran et al., 2010).
Descriptions of species belonging to this genus have recently been prolific; ten novel
species were described in the last five years and O. pituitosum, O. haematophilum,
O. pseudogrignonense, O. rhizosphaerae and O. thiophenivorans with contributions
of the here presented thesis.
The genus contains both, non-pathogenic soil and rhizoplane bacteria and the
facultative pathogenic species O. anthropi and O. intermedium. The pathogens cause
infections in humans that are usually immunocompromised but some strains were
found to cause severe Brucella-like infections in previously healthy humans
(Kettaneh et al., 2003; Ozdemir et al., 2006; Vaidya et al., 2006). Another species,
Ochrobactrum pseudintermedium, was isolated from a patient with severe health
problems (Teyssier et al., 2007) and is presumably pathogenic for humans too.
Scholz et al. (2008b) pointed at the probability of other potential human pathogens
within species like O. tritici, O. haematophilum and O. pseudogrignonense.
In phylogenetic analyses based on 16S rRNA gene and recA sequences, Brucella
strains grouped within the genus Ochrobactrum which means that clear demarcation
criteria for both genera have to be defined (Scholz et al., 2006; Scholz et al., 2008b).
Because of their close relationship and similar genetic properties, Ochrobactrum
species are frequently designated “Brucella-like” and it has been discussed to
combine Brucella and Ochrobactrum into one genus, Brucella, but there is a strong
tendency to keep the names as they are in order to avoid confusion concerning such
an important pathogen. Considering their close relationship and sometimes even
similar disease pattern, it is of great importance to have specific diagnostic tools at
hand that can unambiguously identify pathogenic brucellae and differentiate them
from the less pathogenic and non-pathogenic Brucella-like species.
Brucella and Brucella-like
9
2.1.3. Diagnosis
Classical differentiation between the different Brucella species and biovars is based
on phage typing, sensibility to dyes, oxidative metabolic profiles, CO2 requirements,
H2S production and agglutination with monospecific antisera (Alton et al., 1988).
These typing methods are time-consuming, often subjective and a risk for the
laboratory personnel; that is why methodological improvements are desirable.
Current epidemiological and diagnostic Brucella research, also stimulated by the
bioterrorism debate, has been exploiting novel molecular typing methods to develop
more rapid, reliable and safe diagnostic tools.
Despite the high genetic similarities, a range of different PCR techniques for
differentiation of Brucella species and to some extent also biovars have already been
established. These molecular approaches include analysis of outer-membrane genes
and PCR-RFLP (Ficht et al., 1989; 1996; Cloeckaert et al., 1995; 1996; 2001;
Vizcaino et al., 1997; 2004; Garcia-Yoldi et al., 2005; Al Dahouk et al., 2005), locus
specific conventional and real-time PCR assays targeting different polymorphic
regions (Fekete et al., 1990; Bricker and Halling, 1994; Redkar et al., 2001; Ferrao-
Beck et al., 2006; Garcia-Yoldi et al., 2006; Ratushna et al., 2006), arbitrary primed
and rep-PCR (Mercier et al., 1996; Tcherneva et al., 1996; Fekete et al., 1992;
Tcherneva et al., 2000), ‘infrequent restriction site’ (IRS)-PCR (Cloeckaert et al.,
2003), multilocus sequence typing (Whatmore et al., 2007), multilocus variable
number tandem-repeat analysis (Bricker et al., 2003; Le Fleche et al., 2006;
Whatmore et al., 2006; Garcia-Yoldi et al., 2007; Al Dahouk et al., 2007), AFLP
(Whatmore et al., 2005), and SNP-PCR (Marianelli et al., 2006; Scott et al., 2007;
Fretin et al., 2008; Foster et al., 2008).
Several studies describe PCR assays that make use of the specific occurrence of
the multiple insertion element IS711 which was described by Halling et al. (1993) and
is stable in number and position in the Brucella chromosomes (Bricker and Halling
1994; 1995; Bricker et al., 2000; Cloeckaert et al., 2000; 2003; Ohishi et al., 2004;
Ocampo-Sosa et al., 2005). So, it was shown with a limited set of reference strains
that a multiplex-PCR could identify and differentiate some biovars of B. abortus, B.
melitensis, B. ovis and B. suis biovar 1 and also two vaccine strains. In another
study, the majority (>90%) of the tested B. abortus and B. melitensis strains could be
correctly identified in a real-time multiplex assay, employing only one reverse primer
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(binding IS711 of B. abortus and B. melitensis) and two specific forward primers
(targeting the neighbouring alkB and BMEI1162 gene, respectively) (Probert et al.,
2004). In a similar approach, a real-time PCR assay was developed that could
differentiate between B. abortus, B. melitensis and B. suis biovar 1 (Redkar et al.,
2001). Further analyses showed that marine and terrestrial isolates can be
differentiated by the size of a specific PCR product that is amplified using primers
that bind the bp26 gene and the IS711 palindromic element (Cloeckaert et al., 2000).
Also the novel species B. inopinata can be differentiated from other Brucella species
by a specific IS711 occurrence (Scholz et al., 2010). A comprehensive approach was
made by Hinic et al. (2008) who used unique genetic loci of the six classical species
to develop seven individual reactions for detection of the Brucella genus and the
differentiation between the six species to be used in conventional as well as real-time
PCR. Scholz et al. (2008a) described an assay targeting the conserved gene recA
that detects and differentiates O. anthropi, O. intermedium and Brucella by
conventional PCR in a single reaction. A differentiation between some of the classical
Brucella species was achieved by the use of the relatively time-consuming ‘infrequent
restriction site’ (IRS)-PCR and even characteristic IRS-PCR patterns for B. suis
biovar 2 could be found (Cloeckaert et al., 2003). In another study, DNA
polymorphisms in the genes for the different outer membrane proteins (OMPs; omp2,
omp25, omp31) were examined and tested for differentiation purposes. So it was
shown that strains of B. melitensis are characterized by the lack of the signature
sequence for the restriction enzyme EcoRV in the omp25 PCR product and B. ovis
strains by a 50 bp deletion in the same gene. Furthermore, in the restriction patterns
for the omp2 PCR product, species- and also biovar-specific features were found
(Cloeckaert et al., 1995). A high variability was also found for the restriction patterns
of this PCR product in marine brucellae which does not only hint at the existence of
different species but also of different biovars (Cloeckaert et al., 2001). The target
sequence of another PCR based diagnosis of human brucellosis is omp31, encoding
the 31-kDa Brucella outer membrane protein (Casañas et al., 2001). In this assay,
which has already been adapted to a real-time PCR (Queipo-Ortuño et al., 2005),
Brucella species cannot be differentiated from all members of the closely related
genus Ochrobactrum. SNPs were used in real-time applications to identify B. suis
and differentiate between its biovars (Fretin et al., 2008) and Marianelli et al. (2006)
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reported that the rpoB gene contains enough DNA polymorphisms for the
identification of Brucella spp.
A comprehensive microarray study by Rajashekara et al. (2004) revealed several
differences in the genomes of the classical Brucella species most of which were
insertions or deletions. Genomic fingerprinting is another approach to differentiate
between Brucella species, biovars and strains. REP- and ERIC-PCR (rep-PCR) were
used to examine whether these assays could be used for a differential typing of
brucellae on the basis of the resulting banding patterns (genomic fingerprints)
(Mercier et al., 1996; Techerneva et al., 1996). The two studies yielded inconsistent
results and rep-PCR assays proved to be difficult to reproduce and not the method of
choice for reliable differentiation of species and strains. However, both groups
showed that by the one or the other technique a range of different banding patterns
could be obtained and that even B. canis strains could be differentiated from the
other species by their banding patterns after REP-PCR (Tcherneva et al., 1996).
Complex banding patterns were also found after PCR analyses of Brucella when
short (10mer) and randomly designed primers were used for amplification (RAPD-
PCR) (Fekete et al., 1992; Tcherneva et al., 2000). A fingerprinting method with a
DIG-labeled IS711 probe was successfully used to differentiate between terrestrial
and marine Brucella strains (Ouahrani-Bettache et al., 1996; Bricker et al., 2000). A
similarly high variability in genomic fingerprints was detected in the typing of Brucella
strains after a ‘multi-locus variable number tandem repeats’ analysis. However, the
results showed neither species- nor biovar specificity (Bricker et al., 2003).
The high genomic similarities between Brucella species is a major reason for the
difficulty to differentiate between them on the basis of molecular techniques.
However, studies aimed at typing brucellae into species and biovars indicate that,
despite the close genomic similarity between the different species, there is sufficient
variability to be able to develop a PCR method that cannot only differentiate between
the different species but also the biovars. Especially the studies carried out by Fekete
et al. (1992) and Tcherneva et al. (1996, 2000) inspired us to use the different rep-
PCR and RAPD fingerprinting techniques as the key strategy towards the
identification of regions of variability in the Brucella genomes.
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2.2. Development of a PCR assay for typing and subtyping of Brucella species
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2.3. Brucella microti sp. nov., isolated from the common vole Microtus arvalis
Brucella and Brucella-like
24
Brucella and Brucella-like
25
Brucella and Brucella-like
26
Brucella and Brucella-like
27
Brucella and Brucella-like
28
Brucella and Brucella-like
29
Brucella and Brucella-like
30
Brucella and Brucella-like
31
2.4. Brucella inopinata sp. nov., isolated from a breast implant infection
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2.5. Ochrobactrum pituitosum sp. nov., isolated from an industrial environment
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2.6. Ochrobactrum haematophilum sp. nov. and Ochrobactrum
pseudogrignonense sp. nov., isolated from human clinical specimens
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2.7. Ochrobactrum rhizosphaerae sp. nov. and Ochrobactrum thiophenivorans
sp. nov., isolated from the environment
Brucella and Brucella-like
52
Brucella and Brucella-like
53
Brucella and Brucella-like
54
Brucella and Brucella-like
55
Brucella and Brucella-like
56
Brucella and Brucella-like
57
2.8. Description of Pseudochrobactrum kiredjianiae sp. nov.
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2.9. Pseudochrobactrum lubricantis sp. nov., isolated from a metal-working
fluid
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2.10. Paenochrobactrum gallinarii gen. nov., sp. nov., isolated from air of a
duck barn, and reclassification of Pseudochrobactrum glaciei as
Paenochrobactrum glaciei comb. nov.
Brucella and Brucella-like
68
Brucella and Brucella-like
69
Brucella and Brucella-like
70
Brucella and Brucella-like
71
Brucella and Brucella-like
72
Brucella and Brucella-like
73
2.11. Use of groEL and gyrB sequences for classification of Brucella and
Brucella-like strains
2.11.1. Introduction
The alphaproteobacterial family Brucellaceae (Breed et al., 1957) includes the
genera Brucella (Meyer and Shaw, 1920), Mycoplana (Gray and Thornton, 1928),
Ochrobactrum (Holmes et al., 1988), Pseudochrobactrum (Kämpfer et al., 2006) and
Paenochrobactrum (Kämpfer et al., 2010). Brucellae are major zoonotic pathogens
that are found in a broad spectrum of animal reservoirs. Differentiation between
Brucella species is mainly based on the different hosts they are infecting but
phenotypic and genotypic interspecies variation is low. Applying the widely accepted
species definition of Wayne et al. (1987), the genus Brucella would have to be
considered to be monospecific with the only species Brucella melitensis. In
conclusion, Verger et al. (1985) proposed reclassification of all species recognized at
that time to subspecies of B. melitensis. However, because of the medical and
economic importance of Brucella species, it was decided by the “Subcommittee on
the Taxonomy of Brucella” that the nomenspecies should be retained in order to
avoid confusion (Osterman and Moriyon, 2006).
Next related to the highly infectious genus Brucella is the genus Ochrobactrum.
Ochrobactrum species, predominantly O. anthropi and O. intermedium, can cause a
sometimes brucellosis-like disease in humans too (Young, 1995; Scholz et al.,
2008a,b). During routine identification, Brucella isolates may be misclassified as
members of Ochrobactrum and vice versa and hence, Ochrobactrum strains are
often named Brucella-like. In fact, Brucella and Ochrobactrum must be considered a
monophyletic taxon, as was shown in various studies via DNA-rRNA hybridization,
whole-cell protein analysis, 16S rRNA gene, 16S/23S rDNA internal spacer region 1
(ITS1) and recA sequence comparisons (De Ley et al., 1987; Velasco et al., 1998;
Lebuhn et al., 2006; Scholz et al., 2008b).
Several novel taxa have been assigned to the family Brucellaceae in the last few
years and interest in Brucella-like species has grown due to the bioterroristic potential
of Brucella species. Currently, Brucella consists of nine species, namely B.
melitensis, B. abortus, B. ovis, B. canis, B. suis, B. neotomae, B. pinnipedialis, B.
ceti, B. microti and B. inopinata (Meyer and Shaw, 1920; Buddle, 1956; Carmichael
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and Bruner, 1968; Huddleson, 1929; Stoenner and Lackman, 1957; Foster et al.,
2007; Scholz et al., 2008c; Scholz et al., 2010). Within the genus Ochrobactrum,
fifteen species are recognized today: O. anthropi, O. intermedium, O. grignonense,
O. tritici, O. gallinifaecis, O. lupini, O. oryzae, O. cytisi, O. pseudintermedium, O.
pseudogrignonense, O. haematophilum, O. thiophenivorans, O. rhizoshaerae, O.
pituitosum and O. ciceri (Holmes et al., 1988; Velasco et al., 1998; Lebuhn et al.,
2000; Kämpfer et al., 2003; Trujillo et al., 2006; Tripathi et al., 2006; Zurdo-Piñeiro et
al., 2007; Teyssier et al., 2007; Kämpfer et al., 2007b; Kämpfer et al., 2008; Huber et
al., 2010; Imran et al., 2009). The genus Pseudochrobactrum contains four species,
Ps. kiredjianiae, Ps. asaccharolyticum, Ps. saccharolyticum and Ps. lubricantis
(Kämpfer et al., 2006; 2007a; 2009). A novel, closely related genus,
Paenochrobactrum, with the two species Paenochrobactrum gallinarii and
Paenochrobactrum glaciei, was recently proposed (Kämpfer et al., 2010).
In order to contribute to a stable classification system for the Brucella-
Ochrobactrum group, we have subjected more than 40 Brucella, Ochrobactrum and
several Pseudochrobactrum (“Brucella-like”) strains to sequence analyses of two
housekeeping genes coding for DNA gyrase subunit B (gyrB) and the chaperonin
GroEL (groEL), respectively. The main aim of the study was to evaluate the
discriminatory power of these genes in regard to a collection of Brucella and Brucella-
like type and field strains and their suitability for a rapid taxonomic allocation.
2.11.2. Materials and methods
Bacterial strains
A representative panel of 35 different Ochrobactrum strains representing all currently
described species except for O. ciceri and the type strains of all ten Brucella species
as well as three Pseudochrobactrum type strains were examined. The strains used in
this study are listed in Table 2. Ochrobactrum and Pseudochrobactrum strains were
grown on PYE medium (3 g·L-1 peptone, 3 g·L-1 yeast extract, pH 7.2) at RT. Brucella
strains were grown on trypticase soy agar (TSA) at 37°C in a 5% CO2 atmosphere.
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Table 2. List of strains used for gyrB and groEL sequencing.
Strain Source Geographic origin Species
Brucella
ATCC 25840T sheep New Zealand B. ovis
NCTC 12891T whale n/a B. ceti
NCTC 12890T sea lion n/a B. pinnipedialis
CCM 4915T common vole Czech Republic B. microti
BO1T breast implant wound USA B. inopinata
ATCC 23459T desert wood rat USA B. neotomae
ATCC 23365T dog USA B. canis
Ochrobactrum
LMG 3331T human France O. anthropi
CCUG 50485 human blood Sweden
CCUG 34461 human tracheal secretion Norway
LMG 3305 human blood France
LMG 3313 vagina France
LMG 371 sputum USA
LMG 5438 blood culture UK
DSM 20150 urine of leech, Hirudo sp. Germany
LUP21T (LMG 20667) Lupinus albus Spain O. lupini
LUP23 Lupinus albus Spain
Esc1T Cytisus scoparius nodules Spain O. cytisi
Esc5 Cytisus scoparius nodules Spain
LMG 18957T wheat rhizoplane France O. tritici
CCUG 29689 human blood Sweden
LMG 401 cervix USA
TA93 industrial environment Austria
LMG 3301T human blood France O. intermedium
RMA 16994 human pelvic abscess USA
CCUG 44770 human sputum Austria
TA13 industrial environment Austria
CCUG 39736 human blood Sweden
LMG 5446 bladder USA
CCUG 1838 n/a n/a
DSM 17490T human axillary swab France O. pseudintermedium
CCUG 43465 paper mill Sweden
CCUG 34735 water Sweden
CCUG 30717T human blood Sweden O.
pseudogrignonense
CCUG 43892 human ear (newborn) Norway
DSMZ 17471T Oryza sativa India O. oryzae
CCUG 38531T human blood Sweden O. haematophilum
OgA9aT soil France O. grignonense
CCUG 50899T industrial environment Sweden O. pituitosum
PR17T potatoe rhizospere Austria O. rhizosphaerae
DSM 7216T waste water Germany O. thiophenivorans
Iso 196T Gallus gallus faeces Germany O. gallinifaecis
Pseudochrobactrum
CCUG 46016T human knee aspirate Sweden Ps. asaccharolyticum
CCUG 33852T industrial glue Sweden Ps. sachharolyticum
CCUG 49584T seafood processing plant New Zealand Ps. kiredjianiae
DNA preparation
DNA was prepared from one loopful of cell material of one distinctive colony
suspended in 100 µl of sterile water by 3 cycles of freeze-thawing (Wieser & Busse,
2000) or, in the case of the highly infectious Brucella species, from heat-inactivated
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biomass (cell material was heated at 99°C for 10 min and centrifuged for 2 min at
13000×g) that was then treated in the same way. 0.5-1 µl of the cleared lysate were
used as template in the PCR assays. High-molecular-mass DNA for the DNA-
reassociation experiments was extracted from biomass according to Pitcher et al.
(1989) and concentration of the purified DNA was estimated chemically according to
Richards (1974).
DNA-DNA hybridization
In order to clarify the taxonomical status of the field strains used in this study, a
majority of them was subjected to DNA-DNA hybridizations with DNAs of the type
strains of their suspected nearest relatives. The hybridizations were performed
according to Ziemke et al. (1998) except that, for nick translation, 2 µg DNA was
labelled during a 90 min incubation at 15°C.
Primer design and PCR amplification
Primers are listed in Table 3. The partial gyrB and groEL sequences of Ochrobactrum
and Brucella species were amplified by PCR with primers constructed using available
gyrB and groEL sequence information in the NCBI nucleotide database. The gyrB
primers used in PCR were designed with the help of an alignment of the (partial) gyrB
sequences of B. abortus biovar 1 str. 9-941 (chromosome I, acc. no. AE017223), B.
suis 1330T (acc. no. AE014291; gyrB: AAN29081; nucleotide position 140014 to
142446), B. melitensis bv. 1 str. 16MT (acc. no. AE008917), O. anthropi IAM 14119
(acc. no. AB014971) and Phyllobacterium myrsinacearum IAM 13587 (acc. no.
AB014990). The primers GyrB_f binding to position 916-939 nt (relative to
AAN29081) and GyrB_r binding to position 2118-2141 nt (relative to AAN29081)
were employed to generate a 1226 bp fragment of the entire gyrB gene (AAN29081:
2433 bp). The groEL primers used in PCR were designed with the help of an
alignment of the (partial) groEL sequences of O. anthropi ATCC 49188 (chromosome
II, acc. no. CP000759), B. abortus S19 (acc. no. M82975), B. melitensis 16M (acc.
no. AE008918) and B. suis 1330 (acc. no. AE014292). The primer pair GroEL_f
binding to position -10-16 nt (relative to groEL part of M82975) and GyrB_r binding to
position 1622-1640 nt (relative to groEL part of M82975) were used to generate a
1650 bp fragment including 1640 bp of the groEL gene (AAN29081: 1641 bp). In the
actual Brucella/Ochrobactrum/Pseudochrobactrum alignments, groEL and gyrB
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sequences were shortened to the same length, 1167 bp and 1023-1029 bp,
respectively.
The 50 µl reaction mixture consisted of primers (0.5 pmol/µl), MgCl2 (3 mM),
dNTP’s (0.2 mM each), 10 µl 5x buffer, and TaqDNA Polymerase enzyme (1.25 u,
Promega), 1-2 µl DNA preparation and sterile water. Amplification was carried out in
a Perkin Elmer GeneAmp PCR System 2400 or an Eppendorf Mastercycler. PCR
amplification with all primer pairs was performed using the following conditions: 5 min
initial denaturation at 95°C, followed by 35 cycles of denaturation for 1 min at 95°C,
annealing for 1 min at 66°C and extension for 90 s at 72°C, final extension for 5 min
at 72°C. Of each PCR reaction 5-7 µl were analyzed by agarose gel electrophoresis
(1% w/v in TAE buffer) for the presence of a 1226 bp or 1650 bp product. Most gyrB
PCR products were purified using the QIAquick PCR purification kit and groEL
products had to be excised from a 1.7 % agarose gel and then purified with the
QIAquick gel extraction kit (both QIAGEN) because of interfering by-products.
Table 3. Primers used for PCR and sequencing.
Primer* Primer sequence (5’ -> 3’) Position+
GroEL_f (amp, s) GGA GAG TAA AAT GGC TGC AAA AGA CG 545 (→) 
GroEL_r (amp, s) GAA GTC CAT GCC GCC CAT G 2194 (←) 
Gro_int_f (s) GAA GCC GAA ATC GGC AAG ATG 1017 (→) 
Gro_Pseud_f (amp, s) CGG CGA AGA CCT GCT GAT C 410 (→) 
Gro_Pseud_r (amp, s) GCA ACG ATA CCT TCT TCA ACC G 1793 (←) 
Gro31_32_33_f (s) GTT GCT GCC GGA ATG AAC CC 73 (→) 
GyrB_f (amp) GAT GAT GAT CTT GTG (AG)TA (AGC)CG CAG 916 (→) 
GyrB_r (amp, s) CGA GGT CAT CAT GAC CCA GCT TC 2141 (←) 
GyrB_111206 (s) CAA GGA CAA GCT TGT TTC CTC C 1399 (←) 
*Abbreviations: amp, amplification primer; s, sequencing primer
+Positions are numbered relative to the groEL/groES sequence of Brucella abortus (acc. no. M82975) and gyrB
sequence of Brucella suis (acc. no. AAN29081). Arrows indicate direction of primers (→, forward; ←, reverse). 
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GyrB and groEL sequence analysis
The nucleotide sequences of the gyrB and groEL fragments were determined by
dideoxynucleotide sequencing of both strands with the PCR primers and, if
necessary, also some internal sequencing primers to accomplish incomplete
sequences (Table 3). Sequencing was partly carried out at VBC Genomics, Vienna
and partly at AGOWA, Berlin. Nucleotide sequences were further analysed using the
Chromas 1.45 program. Multiple sequence alignments of partial gyrB and groEL
gene sequences were performed with Clustal X software, version 1.81 (Thompson et
al., 1994) and further processed and analysed with BioEdit 7.0.5.3 (Hall, 1999).
Nucleotide and protein sequence identities were also calculated with BioEdit. The
phylogenetic gyrB (1023-1029 bp) and groEL (1167 bp) trees were obtained by using
the maximum-likelihood method (PHYLIP version 3.66; Felsenstein, 2006). Trees
were drawn with Treeview version 1.5 software (Page, 1996). 100 bootstrap
resamplings were performed to assess the tree topology. Bartonella henselae
Houston-1T (BX897699) was used as an outgroup.
The following groEL and gyrB sequences were taken from existing entries in the
database: O. rhizosphaerae PR17T (FM863819, FM863814), O. pituitosum CCUG
50899T (FM863820, FM863815), O. gignonense OgA9aT (FM863821, FM863816), O.
pseudogrignonense CCUG 30717T (FM863822, FM863817), O. thiophenivorans
DSM 7216T (FM863823, FM863818), B. suis 1330T (AE014291), B. melitensis 16MT
(AE008917), Bartonella henselae Houston-1 (BX897699) and all recA sequences
used for the phylogenetic analysis (acc. nos. given in Fig. 3).
2.11.3. Results and discussion
RecA- and 16S rRNA gene-based phylogenetic analyses of Brucella and Brucella-
like strains have already been successfully employed to separate different
Ochrobactrum species and to distinguish them from the highly pathogenic Brucella
species (Scholz et al., 2006; 2008b). However, the 16S rRNA gene showed a
resolution too low for differentiation between very closely related species and at the
infraspecies level. Since less conserved protein coding housekeeping genes like
recA generally have a higher discriminatory potential than the 16S rRNA gene, which
is in many cases useful for the discrimination of more distantly related species only,
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they are often used in multilocus sequence typing (MLST) for population genetic
purposes or in multilocus sequence analysis (MLSA) to discriminate between closely
related species. Among others, partial gyrB and groEL sequences are often included
in MLST/MLSA studies. The DNA gyrase subunit B gene (gyrB) codes for a type II
topoisomerase responsible for the negative supercoiling of closed circular double-
stranded DNA during genome replication. The chaperonin GroEL (groEL) is a crucial
molecular chaperone that helps to fold proteins in the cell. In order to evaluate the
usefulness of gyrB and groEL sequence analyses for classification of Brucella and
Brucella-like strains, a number of type and field strains were examined. Unlike
previous sequence typing studies, the present work used DNA-DNA hybridization to
determine the species status of most field strains that were included and thus
provided a stable basis for interpretation of the obtained sequence data.
The primers GyrB_f/r and GroEL_f/r, designed for amplification of the respective
genes, could be successfully employed and GyrB_f/r yielded a specific product for all
included Brucella, Ochrobactrum and Pseudochrobactrum strains. GroEL_f/r primers
were not suitable to amplify an appropriate product from DNA of Pseudochrobactrum
strains and more permissive primers had to be constructed for representatives of this
genus. The obtained gyrB and groEL sequences, as well as recA sequences from the
database were used to create multiple sequence alignments which were then
subjected to phylogenetic analyses with the PHYLIP software package. Protein and
nucleotide sequence identity values were calculated with the program BioEdit and
evaluated for species demarcation criteria useful for a rapid taxonomic allocation of
Brucella and Brucella-like strains.
The gyrB sequence proved to be the least conserved of the two examined genes
and recA, as well (Scholz et al., 2006; 2008b), showing a higher resolution at the
subspecies level, whereas groEL was the most conserved gene. Especially in the
groEL phylogenetic maximum-likelihood dendrogram, the deeply branching lineages
showed little statistical significance, indicated by bootstrap values lower than 70%
(Fig. 2). However, the concatenated tree shows high bootstrap support for most
branches which also confirms the comparable clustering of the dendrograms derived
from only a single gene (Fig. 4). In the trees based on groEL, gyrB and recA
sequences, respectively, species clustered according to their taxonomic affiliation
(Figs. 1-3).
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Fig. 1. Maximum-likelihood tree based on the gyrB (1029 nt) nucleotide sequences. The
dendrogram was created from a Clustal X alignment using PHYLIP. Representatives of Brucella and
Brucella-like groups are included (O, Ochrobactrum; B, Brucella; Ps, Pseudochrobactrum). The
numbers at the nodes of the tree indicate bootstrap values for each node out of 100 bootstrap
resamplings (values below 70% not shown). Bartonella henselae Houston-1 was used as outgroup. If
available, accession numbers are listed beside the nominal designation of the strains. The scale bar
indicates 10% divergence. The different clusters are indicated by the numbers 1-7.
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Fig. 2. Maximum-likelihood tree based on the groEL (1167 nt) nucleotide sequences. The
dendrogram was created from a Clustal X alignment using PHYLIP. Representatives of Brucella and
Brucella-like groups are included (O, Ochrobactrum; B, Brucella; Ps, Pseudochrobactrum). The
numbers at the nodes of the tree indicate bootstrap values for each node out of 100 bootstrap
resamplings (values below 70% not shown). Bartonella henselae Houston-1 was used as outgroup. If
available, accession numbers are listed beside the nominal designation of the strains. The scale bar
indicates 10% divergence. The different clusters are indicated by the numbers 1-7.
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Fig. 3. Maximum-likelihood tree based on the recA (684 nt) nucleotide sequences. The
dendrogram was created from a Clustal X alignment using PHYLIP. Representatives of Brucella and
Brucella-like groups are included (O, Ochrobactrum; B, Brucella; Ps, Pseudochrobactrum). The
numbers at the nodes of the tree indicate bootstrap values for each node out of 100 bootstrap
resamplings (values below 70% not shown). Bartonella henselae Houston-1 was used as outgroup. If
available, accession numbers are listed beside the nominal designation of the strains. The scale bar
indicates 10% divergence. The different clusters are indicated by the numbers 1-7.
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Strains of O. pseudogrignonense, Brucella, O. pseudintermedium, O. intermedium,
O. anthropi, O. tritici and Pseudochrobactrum formed recognizable clusters 1-7 in all
trees including the concatenated tree calculated on the basis of gyrB, groEL and recA
sequences. A comparable clustering was also shown by Scholz et al. (2008b) based
on recA sequences only.
Brucella strains formed a distinct clade designated cluster 2 but showed very little
interspecies variability. Compared to the rrs and recA sequences, which showed
100% identity (Scholz et al., 2008b), gyrB and groEL sequences of Brucella species
showed at least some variability: 99.6-100% and 99.3-100%, respectively (excluding
B. inopinata). However, only the strain B. inopinata BO1T clearly differed from the
other species in its gyrB and groEL sequence. This is in agreement with other
exceptional characteristics of this Brucella species (Scholz et al., 2010). According to
the groEL nucleotide sequence, O. haematophilum, O. intermedium, O.
pseudintermedium and O. anthropi are closest related to Brucella, according to gyrB
O. intermedium and O. pseudintermedium. Brucella species can be clearly
differentiated from these Ochrobactrum species in the phylogenetic dendrograms and
by groEL identity values <94.6% (99.3-100% within the Brucella cluster) and gyrB
identity values <88.8% (98.3-100% within the Brucella cluster). Thus, groEL
sequence identities >99% and gyrB sequence identities >98% of a novel isolate
could indicate that it belongs to the genus Brucella.
High sequence identities in both genes (groEL: ≥ 98.7%; gyrB: >96%) were found
within cluster 5 comprising the strains O. anthropi LMG 3331T, O. anthropi CCUG
50485, O. anthropi LMG 3305, O. anthropi LMG 3313, O. anthropi CCUG 34461, O.
anthropi LMG 5438, O. anthropi LMG 371, O. anthropi DSM 20150, O. lupini LUP23
and O. lupini LUP21T. These results reveal a close relationship between the O.
anthropi strains and support the recA-based findings of Scholz et al. (2008b). The
two O. lupini strains could not be distinguished from O. anthropi strains and, hence,
were included in cluster 5, which emphasizes the general difficulty in differentiating
between the two species. Moreover, a very close relationship of O. cytisi ESC1T and
O. cytisi ESC5 to O. anthropi strains was demonstrated. So, they were also assigned
to cluster 5. The close relationships between O. anthropi, O. lupini and O. cytisi
strains are not surprising when considering the high DNA relatedness between the
species that was found by Trujillo et al. (2005) and Zurdo-Piñeiro et al. (2007). The
O. lupini type strain shows 68% DNA reassociation with O. anthropi, which is close to
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the threshold value of 70%. O. cytisi resulted in 66% reassociation with O. anthropi
and 70% with O. lupini. The identity values do not make a differentiation possible
either, with gyrB nucleotide sequence identities of O. lupini being 96.1-98.9% and of
O. cytisi being 95.4-97.9% to O. anthropi (within O. anthropi: 96-100%) and groEL
sequence identities of O. lupini being 98.8-100% and of O. cytisi being 98.2-98.8% to
O. anthropi (within O. anthropi: 98.7-100%). Strains of cluster 5 can be differentiated
from their nearest neighbours by groEL identity values >98% (O. tritici 96-96.7%; O.
oryzae 95.8-96.3%) and gyrB identity values >96% (O. tritici 94.2-95.7%; O. oryzae
92.2-92.8%).
The strains of cluster 6, O. tritici LMG 18957T, O. tritici CCUG 39659 and LMG 401
showed almost identical groEL sequences (99.7-99.9%), while the identities to other
species of the genus were <97%. These results are in excellent accordance with the
data of Scholz et al. (2008b). Also the gyrB identity values >98% within cluster 6,
including strain TA93, and <96% to other Ochrobactrum and Brucella species confirm
the close relationship between the examined O. tritici strains and the separation from
all other species of the genus.
The high nucleotide sequence identities of strains O. pseudintermedium CCUG
43465 und O. pseudintermedium CCUG 34735 in both genes (99-100%) indicate that
they are actually members of this species. Similarly, the high sequence identities in
regard to both genes between the cluster 4 strains O. intermedium TA13, O.
intermedium CCUG 39736, O. intermedium CCUG 44770, O. intermedium CCUG
1838, O. intermedium RMA 16994, O. intermedium LMG 5446 and the type strain of
the species O. intermedium LMG 3301T (groEL: >98.4%; gyrB: >96,7%), and slightly
lower values to other species of the genus (groEL: <96.4%; gyrB: <92.6%) confirm
their affiliation to this species.
All other Ochrobactrum species could also be clearly differentiated from each
other by comparison of sequence identity values and clustering in the phylogenetic
trees. O. haematophilum clustered next to the Brucella cluster and O. oryzae near
the O. anthropi and O. tritici clusters in the gyrB and groEL based dendrograms
(Figs. 1-2). O. pseudintermedium was always near the O. intermedium cluster (Figs.
1-4). O. grignonense and O. pituitosum were nearest to each other in all trees (Figs.
1-4).
In the dendrograms, Pseudochrobactrum species formed a distinct cluster remote
from the two other examined genera. The three species were clearly separated from
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each other by differences in gyrB and groEL sequences. GroEL sequence identities
between the types of the three species were below 94% and gyrB sequence
identities below 91%. A differentiation from all Brucella and Ochrobactrum species
was also possible, the highest identity values being <89.0% in the groEL sequence
and <81% in the gyrB sequence. Only in the groEL phylogenetic tree, Ps.
asaccharolyticum clustered with Ps. saccharolyticum with a bootstrap support of
76%, whereas in the other dendrograms it clusters with Ps. kiredjianiae (Figs. 1-4).
The results from the sequence comparisons of the gyrB and groEL gene showed
that both genes are of excellent value for a differentiation between the genera
Brucella, Ochrobactrum and Pseudochrobactrum and suitable for discriminating
between most Ochrobactrum and Pseudochrobactrum species. Like with recA, both
genes could not be employed to differentiate between Brucella species. Maximum
sequence differences of 1.3% seem not to be sufficient for use of groEL or gyrB as
genetic markers in a Brucella typing system (Table 5). However, this result was not
surprising, since the species concept of the genus Brucella is mainly based on their
different hosts and the genetic background rather suggests the inclusion of all
Brucella species into a single species.
For the strains DSM 20150, CCUG 50485, LMG 5438, LMG 371 and CCUG
34461, sequence comparisons showed that they are affiliated to O. anthropi. The
results of the DNA-DNA hybridization experiments (Table 4) confirmed that they are
actually representatives of the species O. anthropi. For strains LMG 401 and TA93
the gyrB sequence comparison suggested a close relationship with O. tritici. This was
also substantiated by DNA-DNA hybridization results.
The strains DSM 1838, TA13, LMG 5446, RMA 16994, CCUG 44770 and CCUG
39736 clustered with the type strain of O. intermedium LMG 3301T in both, gyrB and
groEL. The DNA-DNA hybridization results revealed their actual affiliation to this
species (Table 4).
Sequence identities of 99.0% (groEL) and 99.3% (gyrB) suggested that strain
CCUG 43465 is a member of the species O. pseudintermedium. Its affiliation to O.
pseudintermedium could be confirmed by DNA-DNA hybridization experiments that
additionally disproved the previous assignment of CCUG 43465 to O. intermedium
(Table 4).
In the primary amino acid sequences, the discriminatory potential of the
phylogenetic markers is drastically reduced (Table 6). Protein sequences showed a
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maximum difference of 4.4% (GroEL) and 11.2% (GyrB) within the genus
Ochrobactrum. Infraspecies variation decreased. In both, the groEL and gyrB
sequences, O. anthropi, O. tritici, O. cytisi and O. oryzae can hardly be differentiated
and there is only 0.5-1% difference to O. intermedium and O. pseudintermedium
(Table 6). In contrast to nucleotide based comparisons, most O. anthropi strains had
identical GroEL protein sequences, except for DSM 20150 and LUP21T. GyrB
retained a certain differentiating power in the protein sequence, except for the very
closely related species of cluster 5.
Sequence comparisons and phylogenetic relationships clearly separated
representatives of the studied genera and discriminated between Ochrobactrum
species as well. On the other hand, high homogeneity in both genes among
members of Brucella was observed, confirming the mono-specificity of the genus.
The results of this study suggest that, based on sequence similarities of the two
genes, Brucella strains can be reliably identified only at the genus level, whereas the
discriminatory power for classification of Ochrobactrum strains is significantly higher.
Together with recA, the two genetic markers could find application in order to reliably
identify respective field strains in a multilocus sequencing approach.
Table 4. Results of DNA-DNA hybridization experiments.
O. anthropi
LMG 3331T lab*
O. intermedium
LMG 3301T lab*
CCUG 34735 lab*
O. tritici
LMG 18957T lab*
O. pseudintermedium
DSM 17490T lab*
LMG 371 97 % - - - -
CCUG 34461 77 % - - - -
DSM 20150 85 % - - - -
CCUG 50485 97 % - - - -
LMG 5438 98 % - - - -
LMG 3301T - - 40 % - -
TA 13 - 96 % - - -
LMG 5446 - 84 % - - -
RMA 16994 - 93 % - - -
CCUG 44770 - 75 % - - -
CCUG 39736 - 73 % - - -
CCUG 1838 - 81 % (↔) - - - 
LMG 401 - - - 82 % -
TA 93 - - - 79 % -
CCUG 43465 - - - - 87 %
*labelled DNA
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3. Genus Francisella
3.1. Introduction
3.1.1. Tularemia
Francisella tularensis is a small, non-motile, Gram-stain negative, non-spore forming
coccobacillus that causes the zoonotic disease tularemia (rabbit fever, deerfly fever)
in humans and especially one of the four subspecies, Francisella tularensis subsp.
tularensis, is generally highly virulent for humans and animals. It causes the severest
form of the disease, the infectious dose being as few as 25 inhaled cells (Saslaw et
al., 1961; Guryčivá, 1998). The other subspecies, F. tularensis subsp. holarctica and
F. tularensis subsp. mediasiatica, are of intermediate virulence, causing mostly non-
lethal disease in humans (Ellis et al., 2002; Olsufjev and Meshcheryakova, 1982;
1983; Sandström et al., 1992). F. tularensis subsp. novicida infection is rare, normally
occurs in immunocompromised hosts only and is linked to water-borne transmission
(Ellis et al., 2002; Hollis et al., 1989). F. tularensis is found throughout the Northern
Hemisphere and the natural reservoirs for the facultative intracellular bacterium in
Europe are predominantly hares and rodents (Sjöstedt, 2007). The distribution of
tularemia concurs with the distribution of holarctical animals (Sjöstedt, 2007).
Arthropods such as ticks and mosquitoes are vectors that transmit F. tularensis.
Humans are infected with the organism mainly through handling infected animals,
consuming contaminated food or water, or inhaling aerosols (e.g. aerosolisation by
using a lawn mower), but also through arthropod bites (Sjöstedt, 2005a).
Tularemia is an acute febrile invasive illness with rapid intracellular proliferation of
bacteria, accumulation of phagocytes and tissue necrosis (Tärnvik and Chu, 2007).
The typical period of incubation of the disease is three to five days after exposure or
contact (Sjöstedt, 2007). The disease starts with unspecific symptoms like fever with
chills, nausea and headache. According to the different clinical presentations,
ulceroglandular and glandular (transmitted through skin or mucous membranes,
90% of European tularemia cases), oropharyngeal (through ingestion of
contaminated food or water) and respiratory tularemia (through inhalation) are
distinguished (Sjöstedt, 2007). Complications of a F. tularensis subsp. tularensis
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infection include life-threatening pneumonia, septicemia, meningitis, endocarditis,
hepatitis and renal failure; disease caused by F. tularensis subsp. holarctica can lead
to nonfatal meningitis and septicemia (Tärnvik and Chu, 2007). A transmission of
tularemia from human to human has not been proved yet (Sjöstedt, 2007).
Biodefense-associated research has shown much interest in F. tularensis since
the 2001 bioterrorist attacks with anthrax in the U.S. because the biological agent is
highly infectious and can be transmitted by aerosol, raising concerns about a
potential use for biological warfare or terrorism (Sjöstedt, 2007; Keim et al., 2007).
The usage of F. tularensis as a biological weapon was discovered shortly before and
during World War II (Dennis et al., 2001). After the war, the U.S. developed
techniques to employ aerosolized F. tularensis organisms as weapons until the BWC
treaty came into force and stockpiled biological weapons had to be destroyed
(Dennis et al., 2001). The former Soviet Union was also reported to have been
engaged in the exploitation of F. tularensis as a biological weapon (Dennis et al.,
2001; Alibek, 1999). In a bioterrorist attack, inhalation of aerosolized organisms or
intake of contaminated water can result in fatal consequences with many casualties.
Although a vaccine is available, it is not equally efficient for the different forms of
tularemia and the two major pathogenic subspecies (Sjöstedt, 2007) and sufficient
quantities may not be at hand in an actual attack because of the short incubation
time. The CDC used a model developed by the World Health Organization
(Anonymous, 1970) to predict the costs of a bioterrorist attack with F. tularensis
(Sjöstedt, 2007). The outcome was that its extraordinary contagiousness, high
morbidity and potential for large-scale dissemination would lead to very high costs.
So, it is listed as a category A biothreat agent by the CDC, together with anthrax,
Clostridium botulinum toxin, Yersinia pestis, smallpox and different viruses causing
hemorrhagic fevers (Sjöstedt, 2007; Keim et al., 2007).
3.1.2. Classification
The genus Francisella belongs to the Gammaproteobacteria and is the only
recognized genus in the family Francisellaceae exhibiting a unique cellular fatty acid
composition (Sjöstedt, 2005a,b). Currently, the genus Francisella comprises the four
species Francisella tularensis, Francisella philomiragia, Francisella noatunensis (syn.
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Francisella piscicida), Francisella hispaniensis (proposed in the course of this thesis;
Huber et al., 2010) and the recently proposed species Francisella asiatica. F.
tularensis is divided into the subspecies F. tularensis subsp. tularensis (type A), F.
tularensis subsp. holarctica (former palaearctica, type B), F. tularensis subsp.
novicida (former F. novicida, Huber et al., 2010) and F. tularensis subsp.
mediasiatica. F. tularensis subsp. holarctica is divided into three biovars: biovar I Erys
(susceptible to erythromycin), biovar II Eryr (resistant to erythromycin) and biovar
japonica (Hofer, 2002; Olsufjev and Meshcheryakova, 1983). F. noatunensis is
divided into the subspecies F. noatunensis subsp. noatunensis and F. noatunensis
subsp. orientalis.
The taxonomical classification of F. tularensis was based on the biochemical and
genetic properties, virulence and geographical origin of strains (Sjöstedt, 2007). F.
tularensis is endemic in the Northern Hemisphere and is especially common in North
America, Russia and Japan (Ellis et al., 2002). However, outbreaks of tularemia were
also reported from Spain, Switzerland, Turkey and Kosovo (Bachiller Luque et al.,
1998; Wicki et al., 2000; Reintjes et al., 2002). Even in parts of Austria, the Czech
Republic and Slovakia, F. tularensis could sporadically be isolated as the cause of
human disease (Hofer et al., 1997). Generally, less virulent F. tularensis subsp.
holarctica is predominantly isolated in Europe, Asia and North America, Francisella
tularensis subsp. mediasiatica is mainly confined to Central Asia and F. tularensis
subsp. tularensis is most abundant in North America (Ellis et al., 2002; Guryčivá, 
1998). F. tularensis subsp. novicida is found rarely but worldwide and F. philomiragia
is present in the Northern Hemisphere only (Keim et al., 2007). F. philomiragia was
isolated from water samples and muskrats in Utah as well as from humans, F.
noatunensis and F. asiatica were isolated from fish and F. hispaniensis from human
blood and urine (Jensen et al., 1969; Hollis et al., 1989; Mikalsen et al., 2007;
Mikalsen and Colquhoun, 2009; Escudero et al., 2010).
Different molecular typing methods identified two different phylogenetic groups
within F. tularensis subsp. tularensis, A.I and A.II (Johansson et al., 2004; Garcia Del
Blanco et al., 2002). The two groups are found in different geographic areas and
altitudes; A.I is predominantly found in the eastern US and in California (same
distribution as the tick vectors Dermacentor variabilis and Amblyomma americanum
and the host Sylvilagus floridanus), A.II is found in the Rocky Mountain region of the
western US (same distribution as the tick vectors Dermacentor andersoni and
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Chrysops discalis and the host Sylvilagus nuttallii) (Farlow et al., 2005). Interestingly,
A.I isolates were found to be of higher virulence to humans than A.II isolates (Staples
et al., 2006).
3.1.3. Diagnosis
Diagnosis of tularemia is traditionally based on the detection of F. tularensis-specific
antibodies in blood and does not discriminate between the pathogenic subspecies
(Keim et al., 2007). The subspecies of F. tularensis are classically differentiated on
the basis of their virulence, citrulline ureidase activity, glycerol and glucose
fermentation (Ellis et al., 2002). The biovars I Erys, II Eryr and japonica of F.
tularensis subsp. holarctica are distinguished based on their susceptibility to
erythromycin and acid production from glycerol (Hofer, 2002). Their similarity in other
characteristics like fatty acids (Jantzen et al., 1979), protein patterns (Sandström et
al., 1988), expression of antigens (Nutter, 1971) and results of biochemical tests
(Hollis et al., 1989) complicate the classification of F. tularensis field strains into
different subspecies and biovars. Moreover, typing according to the phenotype is
often inconsistent with modern genetic bacterial systematics and only partly
applicable for the prediction of phylogenetic relationships (Keim et al., 2007). A
further problem of traditional diagnosis is that the handling of human virulent strains
poses a hazard and should be done at containment level 3 which is laborious and
time-consuming. Therefore, rapid tools for identification and differentiation of
Francisella based on molecular methods as well as highly discriminatory tools for
epidemiological traceback are needed.
In the past decade, a range of different molecular typing methods with taxonomic
ranges of discrimination from family to isolate level have been applied for Francisella:
whole-genome DNA sequencing, 16S rRNA gene sequencing, DNA-DNA
reassociation, ribotyping, whole-genome microarray, pulsed field gel electrophoresis
(PFGE), insertion element-probed restriction fragment length polymorphism (RFLP),
multilocus sequence typing (MLST), amplified fragment-length polymorphism (AFLP),
multilocus variable number tandem repeat analysis (MLVA) and single nucleotide
polymorphism (SNP) analysis (Keim et al., 2007). For differentiation between the
species, subspecies, biovars and strains of F. tularensis, study of short-sequence
tandem repeats (Johansson et al., 2002), insertion element based RFLP (Thomas et
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al., 2003), automated ribotyping (Grif et al., 2003), MLST (Nübel et al., 2006), MLVA
(Johansson et al., 2004; Farlow et al., 2001) and specific PCR-primers and probes
(Forsman et al., 1994; Johansson et al., 2000; Broekhuijsen et al., 2003; Versage et
al., 2003; Tomaso et al., 2006; Molins et al., 2009; Svensson et al., 2009) were
employed. Although the high genomic similarity between the different subspecies of
F. tularensis was frequently confirmed, studies based on DNA microarrays
(Broekhuijsen et al., 2003; Samrakandi et al., 2004), proteom analysis (Hubálek et
al., 2004) and a rep- and RAPD-PCR based typing approach (De La Puente-
Redondo et al., 2000) have shown a certain degree of genomic heterogeneity that
indicated the possibility to find specific markers for the development of rapid
differentiating PCR-tests. These studies already showed interesting approaches to
the identification of the examined Francisella strains, but the presented results do not
convincingly allow for a rapid and reliable identification of Francisella field strains to
the species, subspecies and biovar level. On the one hand, only a limited number of
members of one or more of the different groups was included or representatives of
one or more groups were left out in the studies, or, on the other hand, the methods
were too time-consuming. Moreover, there was no clear indication of a reliable
identification of the examined strains. Therefore, it is possible that the taxonomic
status of the included strains was not adequately assured.
It was a goal of the present thesis to develop a PCR method considering all the
aforementioned points of criticism and able to differentiate between all species,
subspecies and biovars of Francisella in order to allow for a rapid typing of field
strains and prevent misidentification of avirulent or low-virulent strains as virulent F.
tularensis.
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3.2. Description of Francisella hispaniensis sp. nov., isolated from human
blood, reclassification of Francisella novicida (Larson et al. 1955) Olsufiev
et al. 1959 as Francisella tularensis subsp. novicida comb. nov., and
emended description of the genus Francisella
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4. Genus Yersinia
4.1. Introduction
4.1.1. Plague and yersiniosis
Yersinia pestis is the most prominent member of the genus, since it is the causative
agent of one of the most ancient recognized human diseases, plague. It is a small,
Gram-stain negative, non-motile, non-spore forming, facultative intracellular pathogen
found in rodents and their fleas (Bottone et al., 2005). In humans the pathogen can
cause three main forms of plague, bubonic, septicemic and pneumonic plague, which
have a high mortality rate if untreated (Bossi et al., 2004c). Bubonic plague is the
most common clinical form and characterised by swollen lymph nodes, the so-called
buboes (Perry and Fetherston, 1997). After injection of Y. pestis via an infective flea
bite, the microorganisms can multiply intracellularly in macrophages and spread in
the host through the lymphatic system, accompanied by fever, headache, nausea
and other unspecific symptoms (Pujol and Bliska, 2005; Perry and Fetherston, 1997).
Then, the bacteria proliferate extracellularly at regional lymph nodes and cause their
inflammation which leads to the characteristic buboes within 2-8 days (Bottone et al.,
2005). The disease can turn into a severe secondary plague septicemia, pneumonia
or meningitis and cause 40-60% lethality if not treated with antibiotics (Perry and
Fetherston, 1997). Primary septicemic plague is a bacteremia without noticeable
swelling of lymph nodes and symptoms resemble those of septicemias caused by
other Gram-stain negative bacteria. In an advanced stage, septicemic plague may
lead to necrotic fingers, toes, nose or lips (‘Black Death’) (Bossi et al., 2004c). The
mortality rate for this form of plague is 30-50% because diagnosis is often very
difficult (Perry and Fetherston, 1997). The third clinical form is primary pneumonic
plague. The lungs are invaded by the microorganisms and the disease can spread
from person to person or animals to humans through respiratory droplets (Bottone et
al., 2005). This aggressive and deadly form of the disease can cause death in less
than four days with a 90% lethality if untreated and thus a primary pneumonic
plague epidemic would be devastating (Bottone et al., 2005; Perry and Fetherston,
1997).
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In contrast, Y. pseudotuberculosis, although showing a strikingly high degree of DNA
relatedness to Y. pestis (Bercovier et al., 1980a), and Y. enterocolitica cause much
milder, enteric illnesses in humans that seldom lead to death and are mostly
transmitted by the fecal-oral route. Like Y. pestis, Y. pseudotuberculosis is an
intracellular parasite that reaches the lymphatic system (Bottone et al., 2005).
Classical Y. pseudotuberculosis infection in humans causes gastroenteritis with
mesenteric lymphadenitis that may be confused with appendicitis (Ochoa and Cleary,
2006). Symptoms include abdominal pain, fever, scarlatiniform skin rash,
conjunctivitis and erythema nodosum, only sometimes diarrhea and enterocolitis
(Ochoa and Cleary, 2006; Krober et al., 1983). In immunocompromised hosts, the
infection can lead to a severe septicemia and other complications (Ochoa and
Cleary, 2006). Y. enterocolitica, the third pathogenic Yersinia species, causes similar
gastrointestinal manifestations in humans, including mesenteric lymphadenitis,
pseudoappendicitis and also septicemia (Bercovier et al., 1980b; Wormser and
Keusch, 1981). Acute enteritis in children is the most frequent representation
(Bottone et al., 2005). The major animal reservoir for Y. enterocolitica strains that
cause human illness is pigs, but strains of this species can also be isolated from
many other animals (Hurvell, 1981). Infection is most often acquired by eating
contaminated food or drinking contaminated unpasteurized milk or untreated water
(Hurvell, 1981).
The pathogenicity of Y. pestis and the other human pathogenic Yersinia species is
ascribed to virulence factors coded on the chromosome as well as on plasmids
(Brubaker, 1991). A lot of virulence factors are coded on a 70 kb plasmid,
pLCR/pYV/pYVe/pIB1 or pCD1 in Y. pestis, that is present in many but not all strains
of human pathogenic Yersinia species (Ben-Gurion and Shafferman, 1981; Eppinger
et al., 2007). It encodes the type III secretion system and effectors, the so-called
Yops (Yersinia outer proteins) that are secreted into the host cell and hamper its
phagocytic mechanisms and immune response (Trosky et al., 2008). Y. pestis
contains two additional unique virulence plasmids, pMT1/pFra and pPCP1/pPst, or a
chimeric plasmid pMT-PCP, combining the two in Y. pestis strain Angola (Eppinger et
al., 2010), that contribute to the higher virulence of this species and are missing in
the other pathogenic yersiniae (Filippov et al., 1990). The 100 kb plasmid pMT1
encodes different virulence factors, including the fraction 1 (F1) capsular antigen and
murine toxin (Lindler, 2004). The second Y. pestis-specific 9.6 kb plasmid, pPCP1,
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encodes the gene for the plasminogen activator Pla that is necessary for the spread
of the bacterium in the host tissue (Sodeinde and Goguen, 1988; Huang et al., 2006).
The heightened virulence of Y. pestis for humans compared to Y.
pseudotuberculosis and Y. enterocolitica is an important field of research and there
has recently been facilitated a more thorough insight into Yersinia evolution and
pathogenicity, since the genomes of several Y. pestis and Y. pseudotuberculosis
strains were sequenced and compared (Parkhill et al., 2001; Deng et al., 2002; Chain
et al., 2004; Song et al., 2004; Zhou et al., 2004a; Chain et al., 2006; Eppinger et al.,
2007; Garcia et al., 2007; Zhang et al., 2009; Eppinger et al., 2010; Shen et al.,
2010). DNA microarray analyses have also contibuted to a better understanding of
Yersinia virulence (Hinchliffe et al., 2003; Zhou et al., 2004b; Han et al., 2005; Wang
et al., 2007). A high degree of gene inactivation, gene loss, IS-mediated genome
rearrangements and the acquisition of chromosomal regions uniquely conserved in Y.
pestis strains might have led to changes that may also be responsible for the
increased pathogenicity of this species (Chain et al., 2004). Especially the frequent
genome rearrangements are thought to have provided a selective advantage for the
adaption to host environments. Recent genome analyses have revealed a higher
genetic diversity within the species Y. pseudotuberculosis and Y. pestis as previously
thought (Eppinger et al., 2007; 2010). Eppinger et al. (2010) stated that “growing
evidence suggests that the plasmid repertoire of Y. pestis is not restricted to the three
classical virulence plasmids, and that its genetic inventory is partly shared, either due
to common ancestry or lateral exchange, with other human and zoonotic bacterial
pathogens, such as Salmonella enterica [...], Klebsiella pneumoniae, and
Streptococcus equi.”
Whereas the two moderately pathogenic members of the genus, Y. enterocolitica
and Y. pseudotuberculosis, cause infections with a low case-fatality rate and are not
known to have been used in biological warfare, Y. pestis was probably already used
against the enemy during the Middle Ages by throwing the corpses of plague victims
over town walls (Wheelis, 1999). During World War II, Japanese used ceramic
bombs with fleas carrying the bubonic plague and there are also accounts for water
contamination and the distribution of food contaminated with plague bacteria (Harris,
1994; Barenblatt, 2004). Y. pestis appears to be a probable agent for a bioterrorist
attack and is therefore listed as a CDC category A biological threat agent
(http://www.bt.cdc.gov/agent/agentlist-category.asp). The release of aerosolised cells
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could cause an outbreak of primary plague pneumonia (Bossi et al., 2004c). Although
plague bacteria are not very resistant and only live for a short time when released in
the air, they are highly virulent and can therefore infect humans as well as rodents
effectively, the fatality rate being high, especially in regard to plague pneumonia
(Bossi et al., 2004c; Rakin, 2003). Moreover, the worldwide extent of plague
endemic-areas makes them easily accessible and great amounts can be cultured
with minimal equipment (Rakin, 2003). The incubation period is short (1-7 days),
suspensions can be easily aerosolised and infections show similar symptoms to other
diseases like tuberculosis, melioidosis, tularemia or glanders (Rakin, 2003). Strains
containing plasmids carrying multiple-antibiotic resistance (Galimand et al., 1997;
Guiyoule et al., 2001) pose an additional threat in case of a bioterrorist event
involving Y. pestis. The genetic diversity of Y. pestis could also be exploited for a
bioterrorist usage in regard to heightened virulence or hindered diagnosis, treatment
and prevention (Anisimov et al., 2004). An effective and broad plague immunization
without side effects has not been developed yet but there is active research in this
field (Titball and Williamson, 2001; Anisimov et al., 2004; Bubeck and Dube, 2007).
4.1.2. Classification
The genus Yersinia of the family Enterobacteriaceae currently consists of 14 species
(Euzeby, 2010), Y. aleksiciae (Sprague and Neubauer, 2005), Y. massiliensis
(Merhej et al., 2008) and Y. similis (Sprague et al., 2008) being the most recently
described species. The three well-established pathogens Y. pestis, Y.
pseudotuberculosis and Y. enterocolitica are known to cause the more or less severe
diseases in humans described above and are therefore the most studied and
prominent members of the genus. Because of their clinical relevance and the
bioterroristic potential of Y. pestis, Y. pseudotuberculosis and Y. pestis were also a
major focus of this thesis.
Yersinia pestis was originally described by Lehmann and Neumann (1896) as
Bacterium pestis. Based on the phenotypical differences in glycerol fermentation,
nitrate reduction and ammonium oxidation, Devignat (1951) divided this species into
the three biovars Antiqua, Medievalis und Orientalis, a classification which has
recently been challenged (Achtman et al., 2004b; Chain et al., 2006; Anisimov et al.,
2004; Zhou et al., 2004c). Strains of biovar Antiqua were predominately isolated in
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Asia, East and Central Africa, strains of biovar Medievalis in Central Asia and strains
of biovar Orientalis worldwide. An atypical group of Y. pestis strains is named
‘Pestoides’. It is different from the main group by its virulence to rodents and the
ability to ferment rhamnose and melibiose (Martinevskij, 1969). Different molecular
biological studies have shown that it is a heterogeneous group and that strains of this
group are partly biovar Antiqua, Medievalis or not to be typed (Klevytska et al., 2001;
Motin et al., 2002; Radnedge et al., 2001; 2002). Recently, the novel Y. pestis biovar
Microtus was described which can be discriminated from the other groups because it
cannot ferment arabinose, is exclusively pathogenic for small rodents and has a
unique profile of deleted genes and pseudogenes (Zhou et al., 2004c).
Examinations in the field of population genetics (applying MLST, analysis of SNPs,
MLVA, IS100 typing, O-antigen typing) indicated that Y. pestis is a relatively young
species that developed out of Yersinia pseudotuberculosis about 10000 – 40000
years ago (Achtman et al., 1999; Achtman, 2004a; Kotetishvili et al., 2005; Skurnik et
al., 2000; Paradis et al., 2005). This close relationship between Y. pestis and Y.
pseudotuberculosis had already been shown by Bercovier et al. (1980a) based on
the results of DNA-DNA hybridization and by Ibrahim et al. (1993) and Trebesius et
al. (1998) through analysis of the 16S rRNA gene sequences. According to the
currently effective species concept, Y. pestis and Y. pseudotuberculosis are, in fact,
members of a single species, since their DNAs reassociate at a level greater than
70% (Wayne et al., 1987).
4.1.3. Diagnosis
A classical laboratory diagnosis of plague is based on staining techniques (Gram,
Giemsa, Wright or Wayson) subjected to strains isolated from blood, sputum, bubo
aspirate, cerebrospinal fluid and scrapings from skin lesions, biochemical tests,
antigen detection, IgM enzyme immunoassay, immunostaining, direct fluorescent
antibody testing, antibiotic susceptibility testing, hemagglutination and specific phage
lysis (Inglesby et al., 2000; Anisimov et al., 2004). Since these methods are often
time-consuming and the handling of Y. pestis is hazardous for the laboratory
personnel and has to be done in a safety level 3 laboratory, many studies have
aimed at the development of rapid, specific and sensitive typing methods that require
a minimum of infectious sample handling.
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In addition to rather epidemiologically applied MLST, VNTR, MLVA, AFLP, RFLP,
SNP and IS100 analyses (Kotetishvili et al., 2005; Pourcel et al., 2004; Klevytska et
al., 2001; Adair et al., 2000; Achtman et al., 1999; Radnedge et al., 2002; Chain et
al., 2006; Motin et al., 2002), different PCR techniques for a reliable detection of Y.
pestis were developed. These include PCR and nested PCR for the detection of the
plasminogen activator (Pla) gene (Hinnebusch and Schwan, 1993; Engelthaler et al.,
1999; Campbell et al., 1993), yopB (Khushiramani et al., 2006), caf1 and pla (Norkina
et al., 1994) and real-time assays targeting pst (Iqbal et al., 2000), pla (Higgins et al.,
1998; Loïez et al., 2003) and fur (Gabitzsch et al., 2008), multiplex-PCR with different
primer pairs that target the chromosomal DNA and the three virulence plasmids
(Tsukano et al., 1996; Leal and de Almeida, 1999; Woron et al., 2006), separate PCR
assays for detection of chromosomal DNA and the three virulence plasmids
(Neubauer et al., 2000a), detection of Y. pestis signature genes for an unknown
hypothetical protein, a putative prophage protein and methyltransferase (Zhou et al.,
2004b), detection of a Y. pestis-specific 41.7 bp chromosomal region absent in Y.
pseudotuberculosis (Radnedge et al., 2001) and a multiplex real-time PCR for
simultaneous detection of chromosomal DNA and the Y. pestis-specific virulence
plasmids, including an internal control for the PCR (Tomaso et al., 2003). Recently,
two multiplex real-time PCR assays for the detection of a chromosomal target and all
three virulence plasmids were developed (Woron et al., 2006; Stewart et al., 2008).
Increasing the possibility of false-negative results, most PCR assays mentioned can
not unambiguously detected DNA of Y. pseudotuberculosis, except for the ones
developed by Radnedge et al. (2001), Chase et al. (2005) and Matero et al. (2009).
In only one study, the atypical group Pestoides was considered (Tomaso et al.,
2003). None of the studies included specific markers for the novel Y. pestis biovar
Microtus or atypical strains of Y. pseudotuberculosis, e.g. strains that cause FESLF
in humans. This was the impulse for a closer examination of three atypical Y.
pseudotuberculosis strains showing major metabolic characteristics of Y. pestis in the
course of this thesis. The goal was to develop a PCR assay to differentiate between
these atypical Y. pestis-like strains and Y. pestis in order to rapidly and reliably rule
out highly pathogenic Y. pestis strains and subsequent risk for human health.
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4.2. A triplex PCR for differential detection of Yersinia pestis-like atypical
strains of Yersinia pseudotuberculosis
4.2.1. Abstract
The aim of this study was to develop a gel-based PCR test that can identify a group
of atypical Yersinia pseudotuberculosis strains, sharing physiological characteristics
with Yersinia pestis. A set of Y. pestis and Y. pseudotuberculosis strains was
examined for genomic polymorphisms employing rep- and RAPD-PCRs. Genomic
differences possibly suitable for the design of specific PCR primers were detected by
comparison of genomic fingerprints and examined by excising differentiating PCR
products from the gel, cloning them in E. coli, sequencing and comparing them with
available Yersinia genome sequences from the databases. Applying this strategy,
three pairs of novel PCR primers could be developed which were integrated into a
single assay that proved to be specific and robust. Hence, the newly developed
triplex PCR assay is a useful tool to rapidly and reliably detect the atypical Y. pestis-
like strains of Y. pseudotuberculosis and simultaneously differentiate them from Y.
pestis and other Y. pseudotuberculosis strains.
4.2.2. Introduction
Yersinia pestis and Yersinia pseudotuberculosis are pathogenic for both, animals and
humans. Whereas Y. pseudotuberculosis is a less severe, mostly enteric and rarely
fatal pathogen, Y. pestis is the causative agent of plague (Bottone et al., 2005) and is
of special current interest due to its bioterrorist potential. DNA reassociation
experiments showed that Y. pestis and Y. pseudotuberculosis can be considered to
be members of a single species applying the threshold of 70% in DNA-reassociation
(Wayne et al., 1987) and combining the two species in a single species as Y.
pseudotuberculosis subsp. pseudotuberculosis and Y. pseudotuberculosis subsp.
pestis was proposed (Bercovier et al., 1980a). Based on practical concerns for
human welfare, it was later decided to maintain Y. pestis and Y. pseudotuberculosis
as separate nomenclatural species (Judicial Commission of the International
Committee on Systematic Bacteriology, 1985). The close relationship could also be
confirmed by results from multi-locus sequence typing as reported by Achtman et al.
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(1999) who then concluded that Y. pestis was a clone of Y. pseudotuberculosis.
Close relatedness is also reflected by only few physiological differences between the
two species useful for discrimination. Isolates are typically differentiated based on
motility at 28°C, urease activity, acid production from L-rhamnose, melibiose and
their growth rate on nutrient agar (Bercovier et al., 1980a; Bottone et al., 2005).
Recently, we examined three Y. pseudotuberculosis strains (Y716, Y718, Y722)
which exhibited major metabolic characteristics of Y. pestis when tested using the
miniaturized Yersinia identification system (Merlin) as described in Neubauer et al.
(2000b). Like Y. pestis, but unlike Y. pseudotuberculosis, these biochemically
atypical Y. pseudotuberculosis strains were not able to ferment L-rhamnose at 28°C,
a determinant feature at this temperature, and were negative in tests for L-
pyroglutamic acid-β-naphthylamide. 35 out of 36 tested strains of Y.
pseudotuberculosis fermented melibiose at 28°C unlike Y. pestis biogroups Antiqua
and Orientalis and the atypical Y. pseudotuberculosis strains. However, in contrast to
the Y. pestis-like biochemical profile, MLST analysis (Mark Achtman, genes: adk,
argA, aroA, glnA, thrA, tmk, trpE, http://mlst.ucc.ie/mlst/dbs/Ypseudotuberculosis)
confirmed strains Y716, Y718 and Y722 as Y. pseudotuberculosis with sequence
types ST19, ST2 and ST19, respectively, whereas Y. pestis always shows the profile
1-2-1-2-5-2-10 (H.C. Scholz, unpublished data). Growth rate on nutrient agar is also
typical for Y. pseudotuberculosis.
Several PCR-based techniques have been developed in the past which allow
identification of Y. pestis (Campbell et al., 1993; Hinnebusch and Schwan, 1993;
Norkina et al., 1994; Tsukano et al., 1996; Leal and de Almeida, 1999; Engelthaler et
al., 1999; Neubauer et al., 2000a; Radnedge et al., 2001; Zhou et al., 2004b;
Khushiramani et al., 2006) and more recently this set of methods was supplemented
by real-time PCR techniques (Higgins et al., 1998; Iqbal et al., 2000; Tomaso et al.,
2003; Loïez et al., 2003; Chase et al., 2005; Woron et al., 2006; Gabitzsch et al.,
2008; Stewart et al., 2008; Matero et al., 2009). Hence, the atypical Y.
pseudotuberculosis strains were also examined by real-time PCR as described in
Tomaso et al. (2003) to rule out the presence of Y. pestis-specific virulence factors.
As a matter of fact, the most characteristic Y. pestis virulence associated genes pla
on plasmid pPCP1 (encoding the plasminogen activator) and caf1 on plasmid pMT1
(encoding the fraction 1 capsular antigen) could not be detected in this analysis (H.C.
Scholz, unpublished data). However, a negative response does not completely rule
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out the risk of false-negative results since plasmids are sometimes lost. Also the
more stable chromosomal markers for the identification of Y. pestis do not entirely
eliminate the possibility of getting a false-negative result if there is PCR inhibition or
malfunction and even internal amplification controls are not always totally reliable.
Hence, facing their deviant physiological characteristics, which may lead to
misidentification as Y. pestis in a preliminary approach, a reliable and rapid method
for a correct identification of these atypical Y. pseudotuberculosis strains and their
simultaneous differentiation from the severe pathogen Y. pestis and the other Y.
pseudotuberculosis strains is desirable. Therefore, we carried out examinations in
order to develop a cost-effective, simple and rapid PCR assay that allows differential
detection of the Y. pestis-like atypical strains of Y. pseudotuberculosis.
4.2.3. Materials and methods
Bacterial strains and culture conditions
The Yersinia strains used in this study are listed in Table 7. All except Y. pestis
strains were cultivated on 3.3x PYE agar (10 g·L-1 peptone, 10 g·L-1 yeast extract) at
28°C. Y. pestis strains were grown on Columbia agar at 28°C. Strains Y716, Y718
and Y722 were kindly provided by Dr. Alexander Rakin (Max v. Pettenkofer Institut,
München).
Preparation of DNA
DNA was prepared from pure cultures of Y. pestis as described previously (Scholz et
al., 2008a). DNA of Y. pseudotuberculosis and the other Yersinia species was
released subjecting a cell suspension in sterile water to three cycles of freezing in
liquid nitrogen and thawing at 65°C (Wieser and Busse, 2000). Released DNA in the
supernatant obtained after short centrifugation was used as template in PCR.
Genomic fingerprinting and identification of molecular markers
Since previous studies employing rep-PCR and RAPD analysis of Yersinia strains
showed differences in the fingerprinting patterns down to the strain level (Kim et al.,
2003; Makino et al., 1994), we decided to examine our set of Yersinia strains with
these methods in order to identify signature regions useful for differentiation. The
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RAPD primers used in this study are listed in Table 8 and in Huber et al. (2009).
RAPD reactions were carried out in a final volume of 25 μl containing 1x Green 
GoTaq® Flexi Buffer, 2 mM MgCl2 (Promega), 200 μM of each dNTP (Bio Products), 
0.6 U of GoTaq® DNA polymerase (Promega), 8 μM primer (4 μM each when two 
primers were used), and approximately 5 ng of DNA. Reactions were performed
using an initial 5 min denaturation step at 95°C, followed by 45 cycles of 1 min at
95°C, 1 min at an appropriate annealing temperature, 2 min at 72°C, and a final
extension step of 5 min at 72°C. The annealing temperature was varied according to
the melting temperatures of the primers (32-42°C). The resolution of banding
patterns was improved by using a ramp rate of 0.3°C sec-1. Repetitive sequence-
based PCRs with ERIC and REP primers as well as BOXA1R (Table 8) were carried
out as described in Louws et al. (1994).
Table 7. Yersinia strains used in this study, species affiliation and resulting banding
patterns after triplex PCR
Strain Species PCR result (bp)
Y784 Y. pestis 275, 364
NCTC 2028 Y. pestis 275, 364
NCTC 8775 Y. pestis 275, 364
NCTC 8779 Y. pestis 275, 364
NCTC 10029 Y. pestis 275, 364
Kuma Y. pestis bv. Antiqua 275, 373
Yokohama Y. pestis bv. Antiqua 275, 373
M23 Y. pestis bv. Orientalis 275, 364
TS Y. pestis bv. Orientalis 275, 364
G8786 Y. pestis bv. Pestoides 275, 364
Y111T = ATCC 29833T Y. pseudotuberculosis 364, 490
Y117 Y. pseudotuberculosis 364, 490
Y262 Y. pseudotuberculosis 364, 490
Y36 Y. pseudotuberculosis 364, 490
Y716 = PTB22 = 79WA486 atypical Y. pseudotuberculosis 355
Y718 = H706/86 atypical Y. pseudotuberculosis 355
Y722 = 776/88 atypical Y. pseudotuberculosis 355
DSM 13030T Y. enterocolitica subsp. palearctica -
ATCC 29473T Y. ruckeri -
ATCC 33638T Y. kristensenii -
DSM 14987T Y. aleksiciae -
CCUG 52882T Y. similis -
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Amplification products (5 μl from each reaction mixture) were separated by 1.5% 
(w/v) agarose gel electrophoresis in 1x Tris/acetic acid/EDTA running buffer at a
constant voltage of 110 V for at least 90 min. Fragments were visualized with UV light
after staining with ethidium bromide. Interesting bands were excised from the gel and
DNA was eluted with the QIAquick® Gel Extraction Kit according to the
manufacturer’s instructions (Qiagen). PCR products were cloned using the Promega
pGEM®-T Easy Vector System and Escherichia coli strain DH10B according to the
manufacturers’ manual. Inserts were sequenced at VBC-Genomics (Vienna) and
resulting sequences were subjected to database searches (EMBL and GenBank) and
compared to the available Yersinia genome sequences (acc. nos.: CP000720,
CP000308, AL590842, CP000950, AE017042, CP001048, BX936398, CP000668,
CP000305, AE009952, CP000901).
Table 8. List of oligonucleotide primers used for PCR amplification in the novel triplex
assay and for genomic fingerprinting. Primers that produced decisive differences in
genomic DNA fingerprints are indicated in bold.
Primer Oligonucleotide sequence (5’3’) Reference
Y_pspest_f CATGTACTCGCAATGGAATG this study
Y_pspest_r ACATCCGTGACAAGGTGTG this study
Y_pest_f GCATTGATGAGCCTAGTATTTATAAGG this study
Y_pest_r TTCAAAGCCATAGTTAAAGTG this study
Y_pstub_f CACGCTAAGTTACAGTAGCG this study
Y_pstub_r CTCAGATTCGTCAATATCC this study
ERIC2 AAG TAA GTG ACT GGG GTG AGC G Versalovic et al. (1991)
ERIC1R ATG TAA GCT CCT GGG GAT TCA C Versalovic et al. (1991)
REP2-I ICG ICT TAT CIG GCC TAC Versalovic et al. (1991)
REP1R-I III ICG ICG ICA TCI GGC Versalovic et al. (1991)
BOXA1R CTACGGCAAGGCGACGCTGACG Versalovic et al. (1994)
RAPD17 CGT TTC AAT G this study
RAPD18 GTT ACA TCA GTG C this study
RAPD19 TCAACAAGGTG this study
RAPD20 AAA CAT TAT CTG C this study
RAPD21 CAA CCA GCT ATA G this study
RAPD22 CTT AAA AAG GTT this study
RAPD23 AAA TTT GTT TGC this study
RAPD24 CAA AGT TTG TTT GC this study
RAPD25 AGT TTG TTT GC this study
RAPD27 AGT TTA GCT GG this study
RAPD28 TTG CTG GGG this study
RAPD29 AAG TTG TAG CTG this study
RAPD30 CAG CAC CAG C this study
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Triplex polymerase chain reaction assay and cycling conditions
Primers are listed in Table 8. Each 25 µl PCR standard reaction contained 1
GoTaq® Flexi Buffer (Promega) with 2 mM MgCl2 (Promega), 200 µM dNTPs (Bio
Products), 0.75 U Promega GoTaq® polymerase, 5 ng Yersinia DNA and 0.5 µM of
the primers Y_pspest_f, Y_pspest_r and 1 µM of the primers Y_pest_f, Y_pest_r,
Y_pstub_f, Y_pstub_r. A negative control containing no template DNA was included
in the set of reactions. Amplification was carried out in an Eppendorf Mastercycler
with an initial denaturation step of 95°C for 3 min, followed by 35 cycles of 95°C for
30 sec, 59°C for 30 sec and 72°C for 30 sec, and a final extension step of 72°C for 5
min. Aliquots of 3-5 µl of PCR product were analyzed by electrophoresis in 1.5%
(w/v) agarose gels that were stained with ethidium bromide.
Analytical sensitivity and specificity of the triplex PCR assay
The analytical sensitivity of the PCR assay was evaluated after the procedure
described in del Cerro et al. (2002) using Y. pseudotuberculosis type strain Y111T
and the atypical Y. pseudotuberculosis strain Y716. One milliliter of a PYE stationary-
phase culture of each strain was centrifuged for 5 min at 12000g, the pellet was
resuspended in 50 l of distilled water and cells were lysed by three cycles of freeze-
thawing (Wieser and Busse, 2000). The cell debris was removed by centrifugation for
5 min at 12000g, and 3 l of serial tenfold dilutions of the supernatant were used in
triplex reactions to estimate the detection limit. To enumerate the bacteria, serial
dilutions of the same pure cultures were prepared and 100 l aliquots of the
respective dilutions were spread onto PYE agar in duplicates. The specificity of the
assay was tested with cell lysates of several Y. pestis and Y. pseudotuberculosis
strains as well as other Yersinia species (Table 7). Performance of the assay was
assessed by using different thermocyclers (Eppendorf Mastercycler, MWG-Biotech
Primus, Perkin Elmer GeneAmp PCR System 2400) and different polymerases
(Promega GoTaq® DNA polymerase, GE Healthcare illustraTM puReTaq Ready-To-
Go PCR Beads, Bio Products Taq Polymerase One).
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4.2.4. Results
Genomic fingerprinting, analysis of sequences and primer design
In the course of this study, 33 different 9- to 15-mer RAPD primers and combinations
out of them were tested, as well as repetitive sequence-based BOXA1R, ERIC and
REP primers (for sequences and references see Table 8). The results of genomic
fingerprinting confirmed the close relationship of Y. pestis and Y. pseudotuberculosis,
since major differences in the banding patterns were moderate among the two
species. However, minor strain specific differences could often be observed, but it
was difficult to find specific marker bands for a coherent group of strains that
distinguished it from another group. Only primers BOXA1R and RAPD19 showed
bands that could successfully be exploited to clearly distinguish Y. pestis from Y.
pseudotuberculosis and the atypical Y. pestis-like strains from both these species,
respectively (Fig. 5).
Fig. 5. Ethidium bromide-stained agarose gels showing the results of genomic
fingerprinting using BOXA1R (A) and RAPD19 (B) primers with Y. pestis Y784, Y.
pseudotuberculosis strains (Y36, Y111T, Y117, Y262) and the atypical Y.
pseudotuberculosis strains (Y716, Y718, Y722). A The 800 bp band of Y784 and the
slightly smaller band of Y36 were excised, cloned and sequenced. B A slight
difference in length between the ca. 460 bp bands of Y. pseudotuberculosis and the
atypical strains was perceived and confirmed in a second and longer electrophoresis
run (not shown). The respective bands of Y262 and Y722 were excised, cloned and
sequenced. M 100 bp + 1,5 kbp DNA ladder size standard; NC negative
control/sample without template DNA.
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After BOXA1R, a product of approximately 800 bp specific of Y. pestis strains was
identified. A slightly smaller band was observed in the Y. pseudotuberculosis patterns
which was clearly missing in the BOXA1R patterns of the three atypical Y.
pseudotuberculosis strains (Fig. 5). Cloning and analysing the Y. pestis PCR product
revealed a 15 bp deletion in the Y. pseudotuberculosis genome relative to Y. pestis
(deletion coordinates based on Y. pestis CO92 genome sequence AL590842:
4109578-4109592). The insert sequence showed 61.8% identity (620 of 762 bp
overlap) to the insecticidal toxin complex subunit tcaC gene of Yersinia enterocolitica
strain W22703 (AJ920332) (Bresolin et al., 2006).
RAPD19-PCR fingerprints showed a band of approximately 460 bp unique for the
three atypical strains of Y. pseudotuberculosis since it was slightly smaller than the
band observed in the other Y. pseudotuberculosis patterns (Fig. 5). The minor
difference in size was confirmed in a longer electrophoresis run of the Y262 and
Y716 samples (not shown). Cloning and sequencing of this fragment and a
subsequent BLAST database search revealed a variable-number tandem repeat
region in the genomes of Y. pseudotuberculosis and Y. pestis strains (position based
on Y. pseudotuberculosis IP 31758 genome sequence CP000720: 1015661-
1016127). Whereas the atypical Y. pseudotuberculosis strain Y722 and Y.
pseudotuberculosis IP 31758 (acc. no. CP000720) possessed no AGCTAATTG
repeat, the other Y. pseudotuberculosis strains had one (acc. nos. AL590842,
CP000950, CP001048, BX936398) and Y. pestis strains had one to three repeats
(one: Antiqua CP000308, Microtus AE017042, Pestoides F CP000668; two:
Nepal516 CP000305, KIM AE009952; three: Angola CP000901).
Fig. 6. Design of the Y. pestis- and Y. pseudotuberculosis-specific primers Y_pstub_r
and Y_pest_f based on the 15 bp deletion in the genome of Y. pseudotuberculosis.
Shown is part of the alignment of the Y. pestis Y784 761 bp BOXA1R-PCR fragment
(pestis) and the Y. pseudotuberculosis IP32953 sequence from the database (acc.
no. BX936398; pseudotub), resulting from an EMBL-EBI Fasta33 search with the Y.
pestis fragment.
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Exploiting the 15 bp deletion detected by BOXA1R-PCR, a Y. pestis-specific forward
primer (Y_pest_f) and the Y. pseudotuberculosis-specific reverse primer (Y_pstub_r)
were designed as indicated in Fig. 6. The respective reverse and forward primers of
the two primer pairs were set up- and downstream of the deletion, respectively. The
primers were tested in individual PCR assays and Y_pstub_f/r gave a 490 bp
fragment with all Y. pseudotuberculosis strains except for the atypical isolates and no
product with Y. pestis strains. The primer pair Y_pest_f/r gave a 275 bp product with
all Y. pestis strains tested but no product with Y. pseudotuberculosis strains (results
not shown).
Another primer pair (Y_pspest_f/r) was designed based on the region of the
tandemly repeated sequence described above to give a 355 bp product with the
atypical Y. pseudotuberculosis strains and a 364 bp product with Y.
pseudotuberculosis and most Y. pestis strains (373 bp with Y. pestis Nepal and KIM,
382 bp with Y. pestis Angola). When tested in individual PCR, the primer pair
Y_pspest_f/r resulted in the expected amplicons for the examined strains of Y. pestis,
Y. pseudotuberculosis as well as the atypical Y. pseudotuberculosis strains (results
not shown).
Triplex PCR assay
The three developed primer pairs were integrated into a single PCR assay. Results of
application of the novel PCR with DNA samples of Y. pestis, Y. pseudotuberculosis
and the three atypical Y. pseudotuberculosis strains are shown in Fig. 7, and
amplicon sizes of all strains examined in our study are specified in Table 7. The
atypical Y. pseudotuberculosis strains showed a single band of 355 bp, all Y.
pseudotuberculosis strains exhibited two bands of 364 bp and 490 bp, and Y. pestis
strains showed two bands of 275 bp and 364 bp (majority of strains) or 373 bp
(strains Kuma and Yokohama). The negative control without template DNA showed
no amplification products (results not shown). A faint product of approximately 190 bp
detected in several Y. pseudotuberculosis and Y. pestis strains but not in Y716, Y718
and Y722, which probably resulted from an imperfect second binding site of the
Y_pest_r or Y_pstub_f primer, does not hamper the interpretability of PCR results
(Fig. 7). The primers Y_pest_r and Y_pstub_f could theoretically produce a 748 bp
product in Y. pestis strains but this is not promoted by the PCR cycling conditions
and was never observed.
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Fig. 7. Ethidium bromide-stained 1.5% agarose gel of triplex PCR products. Lanes 1
and 11 100 bp + 1.5 kbp DNA ladder size standard; lane 2 Y. pseudotuberculosis
Y111T; lane 3 Y. pseudotuberculosis Y117; lane 4 Y. pseudotuberculosis Y262; lane
5 atypical Y. pseudotuberculosis Y716; lane 6 atypical Y. pseudotuberculosis Y718;
lane 7 atypical Y. pseudotuberculosis Y722; lane 8 Y. pestis TS; lane 9 Y. pestis
Yokohama; lane 10 Y. pestis G8786.
These data demonstrate that the atypical Y. pestis-like strains of Y.
pseudotuberculosis can unambiguously be distinguished from Y. pestis based on a
single band of 355 bp, whereas representatives of both, Y. pestis and Y.
pseudotuberculosis showed an additional band clearly separated from the diagnostic
band of the atypical strains (Fig. 7).
Analytical sensitivity, specificity and performance of the triplex PCR
The limits of detection of the novel PCR assay determined for Y. pseudotuberculosis
Y716 and Y. pseudotuberculosis Y111T were 4,6103 cfuml-1 and 7,7104 cfuml-1
(equivalent to 14 and 231 cfu per PCR), respectively. Since only inactivated material
was available, the sensitivity could not be assessed for Y. pestis. The specificity of
the novel assay was verified by examining DNA of other Yersinia species (Table 7).
By performing a standard PCR targeting the 16S rRNA gene (Lane, 1991) before
using the samples in the triplex assay, it was demonstrated that quantity and quality
of the DNAs were suitable for PCR amplification. The same template DNA samples
did not give amplification products in the triplex assay under the conditions described
above (results not shown). In order to examine the robustness of the developed PCR,
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influences of several parameters were examined. The PCR showed good
performance when different thermocyclers (Eppendorf Mastercycler, MWG-Biotech
Primus, Perkin Elmer GeneAmp PCR System 2400) and polymerases (Promega
GoTaq® DNA polymerase, GE Healthcare illustraTM puReTaq Ready-To-Go PCR
Beads, Bio Products Taq Polymerase One) were used (results not shown).
4.2.5. Discussion
The genomes of Y. pestis and Y. pseudotuberculosis are highly similar and only few
physiological traits are on hand to distinguish between the two taxa, which makes
conventional diagnostic cumbersome (Bottone et al., 2005). Neubauer et al. (2000b)
developed a miniaturised system that detects the different Yersinia species, including
Y. pseudotuberculosis and Y. pestis, on the basis of their metabolic characteristics
with a relatively high test sensitivity. But, recently, three strains affiliated to Y.
pseudotuberculosis, Y716, Y718 and Y722, defied unambiguous typing with this
system in showing some reactions determinant for Y. pestis and thus attracted our
attention.
Because of these exceptional Y. pestis-like features, we developed a cost-
effective, simple and rapid triplex PCR assay the major advantage of which is that a
suspicious isolate, which cannot unambiguously be differentiated from Y. pestis
employing standard diagnostics, is not only classified as non-Y. pestis but it also
allows its identification as an atypical Y. pseudotuberculosis strain. To our
knowledge, this is the first gel-based PCR assay specifically detecting members of an
atypical Y. pseudotuberculosis lineage. Additionally, a distinction between Y. pestis
and classical Y. pseudotuberculosis strains can also be made employing this assay.
The possibility of false-negative results is minimized since the assay was designed
to differentiate between isolates that are already suspected to belong to the Y.
pestis/pseudotuberculosis group, members of which are all positively detected
showing at least one band. Additionally, the band of about 360 bp slighty differing in
size and observed in Y. pestis and all strains of Y. pseudotuberculosis functions as
an internal amplification control. In case of a negative result for the specific product of
a Y. pseudotuberculosis (490 bp) or Y. pestis isolate (275 bp) and only a 364 bp (or
slightly larger) product is present, the isolate is not an atypical Y. pseudotuberculosis
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strain and the PCR should be repeated to clarify whether it belongs to Y. pestis or
classical Y. pseudotuberculosis. No product at all indicates that the PCR did most
probably not work and should also be repeated. DNA of Y. pseudotuberculosis
cannot be positively and unambiguously detected in most of the PCR assays
mentioned in the introduction except for the conventional PCR assays developed by
Radnedge et al. (2001) and the real-time PCR assays by Chase et al. (2005) and
Matero et al. (2009). Another gain is the rapidness of the novel triplex PCR assay
which takes less than 100 min, including the time needed for gel electrophoreses.
Due to the reduced sensitivity inherent in multiplex reactions, this triplex assay is
most useful in the confirmation and characterization of culture isolates.
Recently, a much greater genomic diversity within the species Y.
pseudotuberculosis was revealed than previously presumed (Eppinger et al., 2007).
The three atypical strains examined in the present work might be related to a lineage
of divergent Y. pseudotuberculosis strains causing Far East scarlet-like fever, a
specific clinical form of Y. pseudotuberculosis infection (Somov, 1976). In a BLAST
search of the Y. pestis Y784 DNA fragment sequenced in our study, the genome
sequence of one Y. pseudotuberculosis strain (IP 31758, CP000720; Eppinger et al.,
2007) showed a much lower identity (86.5%) than all the other Y. pseudotuberculosis
strains in the database (98% identity). Due to the low sequence identity, the Y.
pseudotuberculosis-specific primers developed in this study would not target the
published IP 31758 sequence, as it was the case with the three atypical Y.
pseudotuberculosis strains that did not give a product with these primers in the triplex
PCR. Moreover, the genome sequence of IP 31758 is the only one in the database
that shows no repeat of the AGCTAATTG sequence just like the atypical strains in
our study and would give a 355 bp PCR product with the primers Y_pspest_f/r. This
observation suggests that strains Y716, Y718 and Y722 are closely related to Y.
pseudotuberculosis strain IP 31758. Unfortunately, strain IP 31758 or other strains
known to cause FESLF were not accessible to be included in this study.
In any case, employing the newly developed triplex assay, it is possible to reliably
disprove a preliminary physiology-based misidentification of an atypical Y. pestis-like
isolate as Y. pestis and therefore to rapidly – and with a minimum risk of false-
negative results – rule out Y. pestis strains and subsequent high risk for human
health.
Results and discussion
123
5. Comprehensive summary of the papers which are part of
this thesis
The development of improved PCR-based diagnostic methods for the three taxa
Brucella, Francisella and Yersinia, containing highly human pathogenic members,
was central to this thesis. The aim was to develop comprehensive PCR assays to
complement an already existing set of diagnostic conventional and real-time multiplex
PCR assays for biothreat agents insofar as they should not only enable a typing of
species within these three taxonomical groups, but also of not yet detected
subspecies, biovars and other so far unconsidered but significant subgroups. The
exact identification of the pathogen in question beyond the species level can help
health authorities to launch the most appropriate medical treatment and may further
understanding of the disease especially in case of an epidemic. In this context,
taxonomic assignment of so far unclassified strains, including work with a collection
of available reference strains, was necessary.
5.1. Huber, B., Scholz, H. C., Lucero, N. & H.-J. Busse (2009). Development of a
PCR assay for typing and subtyping of Brucella species. Int J Med Microbiol
299, 563-573.
A reliable and rapid tool for discrimination between Brucella species and also biovars
is desirable in order to distinguish less pathogenic or non-pathogenic members of
Brucella from the pathogens with a greater medical impact as well as to avoid
laborious conventional typing of the strains, requiring high biosafety laboratory
precautions. The differential PCR detection of biovars has only partly been achieved
by several studies (Bricker and Halling, 1994; Ocampo-Sosa et al., 2005; Ferrao-
Beck et al., 2006; Fretin et al., 2008). Ochrobactrum species, which are closely
related to Brucella and therefore could be confused in a preliminary diagnosis, have
often been neglected as control organisms in previous Brucella-specific PCR assays
or cross-reactions with them have been ignored (Casañas et al., 2001; Queipo-
Ortuño et al., 2005; Hinic et al., 2008; Fretin et al., 2008). Thus, examinations were
carried out in order to develop a single gel-based multiplex PCR assay allowing not
only for the typing of all known Brucella species at the time of publication but also of
Brucella biovars and does not cross-react with DNA of Brucella-like strains.
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Although RAPD-PCR analyses mostly resulted in very similar banding patterns, they
led to the detection of discriminating genetic polymorphisms in regard to three
Brucella species. RAPD3a-PCR produced a unique band of 446 bp for all B. abortus
strains and a slightly larger fragment with DNA of the other Brucella type and
reference strains. Sequencing of this product revealed a 66 bp deletion in B. abortus
relative to the other species. This difference was used to design genus-specific
primers that simultaneously discriminate B. abortus strains from other brucellae.
RAPD7-PCR produced a 488 bp band in B. ovis and B. pinnipedialis only. The 488
bp fragment was found to be located in a genomic region characteristic of these two
species and therefore suitable to design specific primer. Primers specific for B.
neotomae, B. canis and B. suis biovars 1,3,4 were designed on the basis of deletions
(Rajashekara et al., 2004). Primers for B. suis biovars 2 and 5 were taken from
Ratushna et al. (2006) and all other primers made use of the specific location of the
insertion element IS711 (Scholz et al., 2008c; Bricker and Halling, 1994; Cloeckaert
et al., 2000). All primers were then integrated to constitute one single assay.
The novel 19-primer multiplex assay allowed for a specific detection of Brucella via
an internal genus-specific marker resulting in either a 370 bp or a 436 bp band and
did not amplify any PCR products with DNA of the tested Brucella-like species or
other clinically relevant bacteria. In addition to the common species B. abortus, B.
melitensis, B. ovis and B. suis, it specifically identified B. neotomae, B. pinnipedialis,
B. ceti and B. microti. All B. abortus strains exhibited a unique PCR product of 370
bp. B. melitensis strains, which could not be typed according to biovars, were
discriminated from the other species by a specific 731 bp band and B. ovis strains by
a specific 976 bp band. B. neotomae and B. microti were characterized by a 1370 bp
and a 666 bp band, respectively. B. pinnipedialis and B. ceti both showed a 1140 bp
band and could be distinguished by an additional 569 bp band in the former only. For
the specific detection of B. canis, primers were designed to amplify a 887 bp
fragment. In regard to subtyping feasibilities, the assay can differentiate Brucella
abortus biovars 1, 2, and 4 from biovars 3, 5, 6 and 9 via the presence of a specific
498 bp fragment amplified in the former three biovars. Brucella suis strains were
distinguished into three groups. B. suis biovar 1 is characterized by a specific 285 bp
fragment, biovars 3 and 4 by the presence of only a 217 bp fragment in addition to
the genus-specific 436 bp fragment, and biovars 2 and 5 by an additional 321 bp
fragment.
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When tested in the multiplex assay, all Brucella type and reference strains and the
majority of 118 ﬁeld strains examined could be accurately identiﬁed by their 
respective banding patterns according to their previous typing. B. canis strains were
subdivided into two groups, one exhibiting a unique pattern and the other one,
consisting of several strains with atypical physiological features, a banding pattern
shared with B. suis biovars 3 and 4. This result reflects the general difficulty to
differentiate between B. canis and B. suis biovars 3 and 4 (Fretin et al., 2008; Hinic et
al., 2008; Whatmore et al., 2006; 2007). The other encountered mistypings of B.
melitensis biovars, one B. abortus bv. 6 strain and one B. suis bv. 3 strain are a
minor drawback. They may point to a general problem in the development of a
classification system for biotypes applying molecular methods, since the phenotypic
characteristics exploited in conventional diagnostics generally do not correspond to
the markers chosen for the molecular diagnostic approach and therefore do not
reflect the specific characteristics that determine the respective biotypes.
Hence, the developed PCR assay is useful for rapid identiﬁcation of Brucella at the
species and at the biovar level. Concerning sensitivity and rapidness, a conventional
PCR like this cannot compete with a real-time approach. However, real-time assays
can only be multiplexed with certain restrictions and rarely have considered biovar
typing so far (Fretin et al., 2008). Furthermore, real-time PCR equipment is much
more expensive than a usual PCR apparatus, which is hence easier accessible. A
major advantage of the Brucella multiplex PCR assay is that it can differentiate
between all Brucella species known at the time of the study and a number of biovars.
This was a clear enhancement to comparable assays at the time of publication.
However, the newly-described species Brucella inopinata could not be included in the
assay and it was later shown that this species results in the same characteristic PCR
product as Brucella microti (unpublished results).
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5.2. Kämpfer, P., Martin, E., Lodders, N., Jäckel, U., Huber, B. E., Schumann, P.,
Langer, S., Busse, H.-J. & Scholz, H. (2010). Paenochrobactrum gallinarii gen.
nov., sp. nov., isolated from air of a duck barn, and reclassification of
Pseudochrobactrum glaciei as Paenochrobactrum glaciei comb. nov. Int J Syst
Evol Microbiol 60, 1493-1498.
Scholz, H. C., Nöckler, K., Göllner, C., Bahn, P., Vergnaud, G., Tomaso, H., Al
Dahouk, S., Kämpfer, P., Cloeckaert, A., Maquart, M., Zygmunt, M. S.,
Whatmore, A. M., Pfeffer, M., Huber, B., Busse, H.-J. & De B. K. (2010).
Brucella inopinata sp. nov., isolated from a breast implant infection. Int J Syst
Evol Microbiol 60, 801-808.
Huber, B., Scholz, H. C., Kämpfer, P., Falsen, E., Langer, S. & Busse, H.-J.
(2010). Ochrobactrum pituitosum sp. nov., isolated from an industrial
environment. Int J Syst Evol Microbiol 60, 321-326.
Kämpfer, P., Huber, B., Lodders, N., Warfolomeow, I., Busse, H.-J. & Scholz, H.
C. (2009). Pseudochrobactrum lubricantis sp. nov., isolated from a metal-
working fluid. Int J Syst Evol Microbiol 59, 2464-2467.
Kämpfer, P., Sessitsch, A., Schloter, M., Huber, B., Busse, H.-J. & Scholz, H. C.
(2008). Ochrobactrum rhizosphaerae sp. nov. and Ochrobactrum
thiophenivorans sp. nov., isolated from the environment. Int J Syst Evol
Microbiol 58, 1426-1431.
Scholz, H. C., Hubalek, Z., Sedlácek, I., Vergnaud, G., Tomaso, H., Al Dahouk,
S., Melzer, F., Kämpfer, P., Neubauer, H., Cloeckaert, A., Maquart, M.,
Zygmunt, M. S., Whatmore, A. M., Falsen, E., Bahn, P., Göllner, C., Pfeffer, M.,
Huber, B., Busse, H.-J. & Nöckler, K. (2008). Brucella microti sp. nov., isolated
from the common vole Microtus arvalis. Int J Syst Evol Microbiol 58, 375-382.
Kämpfer, P., Scholz, H. C., Huber, B., Falsen, E. & Busse, H.-J. (2007).
Ochrobactrum haematophilum sp. nov. and Ochrobactrum pseudogrignonense
sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 57,
2513-2518.
Kämpfer, P., Scholz, H., Huber, B., Thummes, K., Busse, H.-J., Maas, E. W. &
Falsen, E. (2007). Description of Pseudochrobactrum kiredjianiae sp. nov. Int J
Syst Evol Microbiol 57, 755-760.
As already stated above, Ochrobactrum and Brucella strains are closely related and
Ochrobactrum strains can hence be considered Brucella-like strains. In fact, Brucella
species always cluster within Ochrobactrum in gene-based phylogenetic analyses
(Scholz et al., 2006; 2008b; chapter 2.11.). Moreover, several Ochrobactrum species
infect humans as well and may have been underestimated as pathogens. It was
previously thought that Ochrobactrum strains can only cause infections in
immunocompromised hosts, but recent publications have also reported infections in
healthy humans (Kettaneh et al., 2003; Ozdemir et al., 2006; Vaidya et al., 2006).
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Scholz et al. (2008b) pointed out the pathogenic potential of not only O. intermedium
and O. anthropi but also other Ochrobactrum species isolated from humans. Because
of their similar properties, strains of Brucella and Ochrobactrum could be confused in
clinical practice, where especially commercial identification tests based on
biochemical features may result in a wrong typing (Scholz et al., 2008a). However,
Brucella-like strains must not be misidentified as Brucella, species of which can
cause brucellosis and are listed as important biothreat agents.
Over the last few years, Brucella-like strains have thus gained in importance and,
in the course of this thesis, a closer examination of Brucella and Brucella-like taxa
was carried out in order to detect genomic differences by use of genomic
fingerprinting and to provide an accurate framework for the specificity test of the later
developed PCR assay. Brucellaceae field strains were characterized applying
biochemical, physiological, chemotaxonomical and genetic methods. Their taxonomic
position was unambiguously determined by DNA-DNA hybridization. As a side effect,
several novel species of the family Brucellaceae were formally described in the
course of this thesis, which notably expanded the concept of this family. With the
proposal of Ochrobactrum pituitosum as a novel species and major contributions to
the description of nine other novel members of the Brucellaceae (Brucella microti,
Brucella inopinata, Ochrobactrum rhizosphaerae, Ochrobactrum haematophilum,
Ochrobactrum thiophenivorans, Ochrobactrum pseudogrignonense, Ochrobactrum
pituitosum, Pseudochrobactrum kiredjianiae, Pseudochrobactrum lubricantis,
Paenochrobactrum gallinarii), we greatly contributed to the awareness that the family
contains more species and that the genus Brucella is more diverse than previously
thought.
The two novel Brucella species, B. microti and B. inopinata, are both exceptional
in comparison to other brucellae concerning their highly active metabolism. Affiliation
to Brucella, however, was confirmed by DNA-DNA hybridization as well as by means
of polyamine analysis, their polar lipid profile, fatty acid profile and quinone system.
B. inopinata was found to be the most outstanding of all currently described Brucella
species. Among other differences, it showed a unique Brucella-specific insertion
element IS711 banding pattern, exhibited a unique 16S rRNA gene sequence,
significantly lower sequence similarities in various housekeeping genes and in genes
encoding outer-membrane proteins. Moreover, B. inopinata could be differentiated
from other brucellae via its polar lipid profile, based on the absence of an unknown
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aminolipid AL2 (present in B. microti and the genus Ochrobactrum) and the presence
of an unknown polar lipid L4 (present in B. microti but not in B. abortus and B.
melitensis).
The Ochrobactrum isolates described as novel species all showed similar
chemotaxonomic results (major ubiquinone Q-10; major polyamines spermidine,
putrescine and sym-homospermidine; major polar lipids phosphatidylethanolamine,
phosphatidylmonomethylethanolamine, phosphatidylglycerol, diphosphatidylglycerol,
phosphatidylcholine and the characteristic aminolipid AL2; major fatty acids C18:1ω7c
and C19:0 cyclo ω8c). However, the results of DNA-DNA hybridization and
physiological and biochemical tests enabled a genotypic and phenotypic
differentiation of the isolates from all other described Ochrobactrum species.
Pseudochrobactrum species showed some major chemotaxonomical differences
to Brucella and Ochrobactrum. They exhibited a polyamine pattern lacking sym-
homospermidine and the polar lipid profile is missing AL2 which is useful for
differentiating the genus from Ochrobactrum. However, the examined Brucella type
strains of B. abortus, B. melitensis and B. inopinata also lack AL2. 16S rRNA gene
and recA sequence similarities to strains of Brucella and Ochrobactrum, together with
chemotaxonomic data allow for a clear differentiation from these genera. In
phylogenetic dendrograms derived from gyrB and groEL sequence alignments,
Pseudochrobactrum species cluster separately and also the calculated identity
values clearly separate them (chapter 2.11.).
A novel genus, Paenochrobactrum, with the type species Paenochrobactrum
gallinarii was described on the basis of characteristic polyamine patterns (major
compound is putrescine) and polar lipid profiles (especially the presence of a
“stretched aminolipid”) and because its members form a distinct lineage in the 16S
rRNA gene sequence-based phylogenetic tree.
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5.3. Huber, B., Escudero, R., Busse, H.-J., Seibold, E., Scholz, H. C., Anda, P.,
Kämpfer, P. & Splettstoesser, W. D. (2010). Description of Francisella
hispaniensis sp. nov., isolated from human blood, reclassification of Francisella
novicida (Larson et al. 1955) Olsufiev et al. 1959 as Francisella tularensis
subsp. novicida comb. nov. and emended description of the genus Francisella.
Int J Syst Evol Microbiol 60, 1887-1896.
Francisella tularensis is an important pathogen, but not all subspecies are of equal
pathogenicity. F. tularensis subsp. tularensis and F. tularensis subsp. holarctica
frequently cause infections in humans that can be very severe, especially in the case
of the highly contagious F. tularensis subsp. tularensis, but even within this
subspecies two genetically distinct populations (A.I and A.II), which exhibit different
manifestations of the disease, were recognized (Farlow et al., 2005; Staples et al.,
2006). These known differences in virulence between subspecies and genotypes of
F. tularensis and a detected inherent resistance to antibiotics of some uncommon
Francisella strains (Kugeler et al., 2008) may be critical for the clinical management
of tularemia patients. Therefore, as well as for environmental studies, aiming at
identification of potential zoonotic reservoirs of F. tularensis and in epidemiology,
rapid typing and subtyping of bacterial strains belonging to the genus Francisella is
crucial.
Since previously published assays did not include the species F. philomiragia, F.
piscicida (= F. noatunensis) and F. hispaniensis and cannot discriminate between all
F. tularensis subspecies, bio- and genotypes in one step, examinations were carried
out in order to develop a comprehensive multiplex assay that comes up to all these
needs.
RAPD-PCR analysis identified a unique 201 bp band for F. piscicida, a 1259 bp
band for F. philomiragia and a 770 bp band for F. hispaniensis. Based on the
sequence information obtained through cloning and sequencing of the RAPD
generated fragments, three different primer pairs for a specific detection of the
respective species could be designed. For F. tularensis subsp. mediasiatica, a
specific primer pair was designed on the basis of a variable genomic region detected
in the published genome sequence of this subspecies in the course of database
searches. The RD1 region of difference (Broekhuijsen et al., 2003) was used to
design an appropriate forward primer for the specific detection of F. tularensis subsp.
tularensis, F. tularensis subsp. holarctica and its biovar japonica (reverse primer
borrowed from Broekhuijsen et al.) and a primer pair specific for F. tularensis subsp.
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novicida. An additional primer pair taken from Molins-Schneekloth et al. (2007)
enabled a further distinction between F. tularensis subsp. tularensis genotypes A.I
and A.II.
The primers were integrated to comprise the first diagnostic PCR assay to detect
all Francisella species, subspecies and several biovars in a single reaction. F.
piscicida, F. philomiragia and F. hispaniensis were characterized by one specific
product each, a 172 bp band, a 962 bp band and a 462 bp band, respectively. All F.
tularensis subspecies, except for F. tularensis subsp. tularensis A.II, showed a
characteristic 369 bp band which was also the feature to discriminate A.II strains from
the A.I genotype. F. tularensis subsp. novicida had an additional band of 1395 bp, F.
tularensis subsp. mediasiatica one of 1132 bp, F. tularensis subsp. tularensis one of
1325 bp, F. tularensis subsp. holarctica one of 629 bp and biovar japonica one of 840
bp. A further species, Francisella asiatica, has only recently been proposed and
could not be considered in the assay.
All type and reference strains and the 24 examined field strains could be
successfully typed according to their previously determined affiliations. The
taxonomical status of several strains, which were used for the evaluation of the novel
14-primer assay, was determined to the species level by DNA-DNA hybridization.
This adds to the accuracy of the assay, while it is still not the standard to assure the
taxonomical position of test strains with this method.
A strain isolated from human blood and affiliated to the genus Francisella according
to 16S rRNA and recA gene sequencing was confirmed to be a novel Francisella
species by DNA-DNA hybridization and the name F. hispaniensis was proposed. F.
hispaniensis showed a quinone system typical of francisellae (mainly ubiquinone Q-
8), a polar lipid profile with the major components phosphatidylethanolamine,
diphosphatidylglycerol, phosphatidylcholine and an unknown aminophospholipid
(APL4) and phospholipid (PL3) and a typical fatty acid profile, primarily consisting of
C10:0, C14:0, C16:0, C18:0 3-OH and C18:1ω9c. Biochemical tests allowed a phenotypic
differentiation of the novel species from other members of the genus.
The polar lipid profile of F. hispaniensis was almost indistinguishable from the one
of F. tularensis subsp. tularensis type strain. Also the other three F. tularensis
subspecies showed most similar profiles. F. philomiragia and F. piscicida (= F.
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noatunensis) type strains, on the contrary, lacked a major aminophospholipid (APL4),
which can be used for their discrimination from F. hispaniensis and F. tularensis.
The proposed species, Francisella hispaniensis, together with four other species,
F. piscicida (= F. noatunensis comb. nov.), F. tularensis (subspecies tularensis,
holarctica, mediasiatica and novicida), F. philomiragia and F. asiatica, currently
comprises the remote standing but medically important genus Francisella.
Chemotaxonomical examinations of members of Francisella also led to an emended
description of the genus, which had so far lacked inclusion of data on the polar lipid
profile and quinone system. The proposed reclassification of F. novicida as a fourth
subspecies of F. tularensis, mainly on the basis of DNA relatedness values (>85%),
chemotaxonomical characteristics (fatty acid and polar lipid profiles) and an almost
complete 16S rRNA gene sequence similarity to F. tularensis, was objected to by
Johansson et al. (2010). Their major arguments for keeping the species separate
were “differences in phenotype including chemotaxonomic markers, distinct
ecological roles, different clinical and epidemiological characteristics, and differing
abilities and modes of invasion and mechanisms of tissue damage in mammals” as
well as practical considerations and recent genomic evidence for the evolution of F.
tularensis “as a population lineage disconnected from F. novicida” (Johansson et al.,
2010). A response to the objections was then written by Busse et al. (2010), in which
most arguments were put into perspective or refuted.
5.4. A triplex PCR for differential detection of Yersinia pestis-like atypical strains of
Yersinia pseudotuberculosis
Gel-based PCR methods to type pathogenic Yersinia strains beyond the species
level are rare (e.g. Bogdanovich et al., 2003). In the course of this thesis, DNA
samples of Y. pestis and Y. pseudotuberculosis isolates, including biovars and
atypical strains, were subjected to RAPD- and rep-PCR analyses in order to detect
genomic differences usable for PCR typing methods. Whereas no appreciable
differences were found within Y. pestis (e.g. for biovars Pestoides and Microtus), a
RAPD-PCR assay produced a differentiating band for three atypical strains of Y.
pseudotuberculosis that show major metabolic characteristics of Y. pestis, which was
then cloned, sequenced and analysed. Facing the deviant metabolic characteristics
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of these strains, which may lead to misidentification as Y. pestis in a preliminary
approach, the detected genomic variation was used for the development of a PCR
assay to differentiate between these atypical Y. pestis-like strains and Y. pestis in
order to rapidly rule out the presence of highly pathogenic Y. pestis strains.
The 460 bp product unique for the three atypical Y. pseudotuberculosis strains
Y716, Y718 and Y722 revealed one to three 9 bp repeats in Y. pestis and other Y.
pseudotuberculosis strains relative to the atypical strains. This 9 bp to 27 bp
difference was exploited for the design of primers to amplify a small product (355 -
382 bp) including the variable-number tandem repeat region in order to enable a
differentiation of strains. A BOXA1R PCR product was found to be unique for Y.
pestis strains. The analysis of this fragment showed a 15 bp deletion in the Y.
pseudotuberculosis genome relative to Y. pestis, which could be used to design both,
a Y. pestis and Y. pseudotuberculosis specific primer pair to give a 275 bp product
with Y. pestis strains and a 490 bp fragment with strains of Y. pseudotuberculosis.
The three developed primer pairs were then integrated to form a diagnostic triplex
PCR assay for a differential detection of the atypical Y. pseudotuberculosis strains.
The primers for differentiation of Y716, Y718 and Y722 produced the expected 355
bp product with these three strains, as well as a 364 bp band in all tested Y.
pseudotuberculosis and Y. pestis strains, except for strains Kuma and Yokohama
(373 bp resulting from two repeats). Additionally, typical Y. pseudotuberculosis
strains produced a unique band of 490 bp and Y. pestis strains one of 275 bp.
The determined detection limits for the triplex assay revealed a moderate
sensitivity and performance was robust. So the assay is most useful for the
characterization of culture isolates. Other Yersinia type species were tested negative
in the novel PCR assay, confirming its specificity. A clear strength of the Yersinia
triplex assay is, that a suspicious isolate, which cannot unambiguously be
differentiated from Y. pestis employing standard diagnostics, is not only classified as
non-Y. pestis but it also allows its identification as an atypical Y. pseudotuberculosis
strain. Additionally, the assay is cost-effective, rapid and easy to perform. This is the
first PCR assay presented that allows for a specific detection of members of an
atypical Y. pseudotuberculosis lineage and its impact might increase if the three
atypical strains, that show some striking parallels with a Y. pseudotuberculosis strain
causing Far East scarlet-like fever, actually prove to be related to these unusual
pathogens. However, this will be left to further analyses.
Conclusion
133
6. Conclusion
In science fiction stories, tools for an ultra-rapid medical diagnosis, like Star Trek’s
“Medical Tricorder”, a fantastic real-time analyser which can accurately detect the
trigger responsible for a disease in vivo, are frequently imagined future innovations.
Actually, scientists all over the world are engaged in steadily improving the potential
of diagnostic tools, especially for bacterial pathogens and viruses, in order to make
medical diagnosis easier, more accurate and faster and therefore increase human
chances of recovery. Rapid, specific and sensitive identification of biothreat agents
has become an important field of research over the last decade because of the
heightened awareness regarding bioterrorist issues. For these diagnostic purposes,
PCR was an invaluable innovation, since PCR-based techniques can replace much
of the often cumbersome and hazardous handling of pathogenic microorganisms in
the laboratory, are usually less time-consuming and the interpretation of results is
less subjective.
The gel-based PCR assays for the highly pathogenic taxa Brucella, Francisella
and Yersinia pestis/pseudotuberculosis developed in this study are important novel
methods, especially in regard to their discriminatory power. Apart from recently
described Brucella inopinata and proposed Francisella asiatica, the rapid and specific
Brucella and Francisella diagnostic assays have the power to identify a suspected
Brucella or Francisella isolate to the species, subspecies and in many cases also to
the biovar level, which made them the most comprehensive diagnostic tools at the
time of publication. The novel Yersinia assay can identify members of an atypical Y.
pseudotuberculosis lineage and differentiate them from other Y. pseudotuberculosis
and most closely related Y. pestis strains. Hence, the assays minimize contact with
the pathogens in the laboratory, provide information for taking the appropriate
medical measures in case of an infection with one of the strains since they can
distinguish the highly pathogenic from the less or non-pathogenic members of the
taxa. A major strength of all the novel assays, apart from their highly differentiating
potential, is the detection of all known members of the taxa via at least one distinctive
band, avoiding the risk of false negative results which could be fatal in case of these
severe pathogens.
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All assays developed in this study employ conventional gel-based PCR that is usually
– and especially if multiplexed – not as sensitive as modern real-time PCR. However,
real-time equipment is more expensive and requires more know-how than
conventional PCR. This is of importance if considering that brucellosis and plague
are diseases primarily affecting developing nations where expensive technology
might not be present in hospitals and laboratories. Furthermore, the number of
targets is still more restricted in multiplex real-time PCR assays than in conventional
PCR (Bahrdt et al. 2010).
A negative aspect of the chosen strategy of applying arbitrary PCR for the
detection of biomarkers was that it was often not possible to assign the detected
regions of difference to a specific known gene or another previously well studied
genomic region. So, little could be found out about the genetic stability and other
features of the target, the usefulness of which for differential detection could only be
evaluated by testing the specificity of the designed primer pairs with all available field
strains. Several primers had to be modified or discarded because they did not work
as expected with all tested members of a group. Only primers that gave clear,
unambiguous results were further integrated into the multiplex assays. For some
species or subgroups, e.g. Brucella neotomae and Francisella tularensis subsp.
tularensis, it was difficult to get a satisfactory set of different test strains since they
are not very common and only few strains have been isolated worldwide or require
special safety measures and are therefore rarely cultured and passed on. Thus, the
assays will have to stand the final test in other laboratories that have access to more
field strains. None of the developed assays was evaluated regarding performance
with clinical samples. As moderate sensitivity is inherent to most multiplex reactions,
the detection limit is often a bit higher than for assays employing only one primer pair.
The evaluation of the assays using clinical and environmental samples as well as
testing them with a wider range of field strains will be left to further analyses.
To enhance the power of the presented novel assays, especially for clinical
diagnostic purposes that seek to avoid culture of pathogenic bacteria, further studies
could take the results of these thesis as a basis for a comprehensive real-time –
though restricted in multiplex use – or DNA chip approach, possibly intended to
detect a range of different bacterial biothreat agents beyond the species level in one
go. The developed assays could also contribute to an approach employing the
modern Lab-on-a-Chip technologies that are especially attractive for biomedical
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applications as well as defence research projects for portable biowarfare agent
detection systems. This innovative method allows for laboratory functions and
processes like sample preparation, DNA-amplification and electrophoresis to be
carried out on a miniaturized chip which can be made of different types of material,
like polymers, glass or silicon (Herold and Rasooly, 2009). Fluids can flow through
tiny channels in a controlled way and appropriate sensors, e.g. optical or
electrochemical sensors, can be mounted on this device. Such chips, when
technically fully matured, are definitely a step towards science-fiction tools like the
“Medical Tricorder”.
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